{
    "total": 2,
    "trials": [
        {
            "nci_id": "NCI-2020-02022",
            "nct_id": "NCT04190628",
            "protocol_id": "ABM1310X1101",
            "ccr_id": null,
            "ctep_id": null,
            "dcp_id": null,
            "other_ids": null,
            "associated_studies": null,
            "outcome_measures": [
                {
                    "name": "Exploratory progression free survival (PFS)",
                    "description": "Preliminary efficacy of ABM-1310 as a single agent",
                    "timeframe": "Up to study discontinuation (an average of 1 year)",
                    "type_code": "OTHER_PRE_SPECIFIED"
                },
                {
                    "name": "Determine Maximum Tolerated Dose (MTD) / Recommended Phase 2 Dose (RP2D)",
                    "description": null,
                    "timeframe": "End of Cycle 1 (each cycle is 28 days) or up to treatment discontinuation (an average of 6 months)",
                    "type_code": "PRIMARY"
                },
                {
                    "name": "Number of participants with treatment-related adverse events as assessed by CTCAE v5.0",
                    "description": "Safety and tolerability of ABM-1310 as a single agent",
                    "timeframe": "Up to 30 days from treatment discontinuation",
                    "type_code": "SECONDARY"
                },
                {
                    "name": "Number of participants with abnormal laboratory values",
                    "description": "Safety and tolerability of ABM-1310 as a single agent",
                    "timeframe": "Up to 30 days from treatment discontinuation",
                    "type_code": "SECONDARY"
                },
                {
                    "name": "Area under the concentration time curve (AUC)",
                    "description": "Pharmacokinetic (PK) profile of ABM-1310 as a single agent",
                    "timeframe": "Up to Day 1 of Cycle 2 (each cycle is 28 days)",
                    "type_code": "SECONDARY"
                },
                {
                    "name": "Maximum plasma concentration (Cmax)",
                    "description": "Pharmacokinetic (PK) profile of ABM-1310 as a single agent",
                    "timeframe": "Up to Day 1 of Cycle 2 (each cycle is 28 days)",
                    "type_code": "SECONDARY"
                },
                {
                    "name": "Steady-state concentration (Css)",
                    "description": "Pharmacokinetic (PK) profile of ABM-1310 as a single agent",
                    "timeframe": "Up to Day 1 of Cycle 2 (each cycle is 28 days)",
                    "type_code": "SECONDARY"
                },
                {
                    "name": "Time to maximum plasma concentration (Tmax)",
                    "description": "Pharmacokinetic (PK) profile of ABM-1310 as a single agent",
                    "timeframe": "Up to Day 1 of Cycle 2 (each cycle is 28 days)",
                    "type_code": "SECONDARY"
                },
                {
                    "name": "Half-life (T1/2)",
                    "description": "Pharmacokinetic (PK) profile of ABM-1310 as a single agent",
                    "timeframe": "Up to Day 1 of Cycle 2 (each cycle is 28 days)",
                    "type_code": "SECONDARY"
                },
                {
                    "name": "Objective Response Rate (ORR)",
                    "description": "Preliminary efficacy of ABM-1310 as a single agent",
                    "timeframe": "Up to study discontinuation (an average of 1 year)",
                    "type_code": "SECONDARY"
                },
                {
                    "name": "Disease Control Rate (DCR)",
                    "description": "Preliminary efficacy of ABM-1310 as a single agent",
                    "timeframe": "Up to study discontinuation (an average of 1 year)",
                    "type_code": "SECONDARY"
                },
                {
                    "name": "Duration of Response (DOR)",
                    "description": "Preliminary efficacy of ABM-1310 as a single agent",
                    "timeframe": "Up to study discontinuation (an average of 1 year)",
                    "type_code": "SECONDARY"
                },
                {
                    "name": "Exploratory preliminary efficacy in patients by types of BRAF V600 mutation",
                    "description": "Preliminary efficacy of ABM-1310 as a single agent",
                    "timeframe": "Up to study discontinuation (an average of 1 year)",
                    "type_code": "OTHER_PRE_SPECIFIED"
                }
            ],
            "amendment_date": null,
            "current_trial_status": "Active",
            "current_trial_status_date": "2020-05-07",
            "start_date": "2020-06-16",
            "start_date_type_code": "ACTUAL",
            "completion_date": "2021-12-01",
            "completion_date_type_code": "ANTICIPATED",
            "record_verification_date": "2020-08-01",
            "brief_title": "Safety of ABM-1310 Monotherapy in Patients With Advanced Solid Tumors",
            "official_title": "A Phase I, First-In-Human, Multicenter, Open-Label Study of ABM-1310, Administered Orally in Adult Patients With Advanced Solid Tumors",
            "acronym": null,
            "keywords": [
                "Melanoma",
                "Colorectal Cancer",
                "Glioblastoma",
                "Cholangiocarcinoma",
                "Non-small Cell Lung Cancer",
                "Thyroid Cancer",
                "Ovarian Cancer"
            ],
            "brief_summary": "This is a Phase I, First-In-Human, open label, dose escalation study to evaluate the safety, tolerability, and pharmacokinetics of ABM-1310. A \"3+3\" design will be used to determine MTD and RP2D.",
            "detail_description": "This is a first-in-human, phase I clinical study with ABM-1310, an investigational, oral,\n      small molecule B-Raf inhibitor in patients with documented BRAF V600 mutation and locally\n      advanced or metastatic solid tumors such as melanoma, colorectal cancer, glioblastoma,\n      cholangiocarcinoma, non-small cell lung cancer, thyroid cancer, or ovarian carcinoma who have\n      no effective standard treatment options available. The primary objective of this study is to\n      determine the Maximum Tolerated Dose (MTD) and/or the Recommended Phase II Dose (RP2D).\n\n      The starting dose of ABM-1310 is 25 mg po bid, and dose escalation will be guided by a \"3+3\"\n      design. ABM-1310 will be administered twice daily on a continuous schedule. Each treatment\n      cycle consists of 28 days.\n\n      Dose limiting toxicity (DLT) will be evaluated and managed per the pre-defined DLT criteria\n      and rules specified in the protocol. MTD and/or RP2D will be confirmed in a dose confirmation\n      cohort.",
            "classification_code": null,
            "interventional_model": "SEQUENTIAL_ASSIGNMENT",
            "study_source": "Industrial",
            "accepts_healthy_volunteers_indicator": "NO",
            "study_protocol_type": "Interventional",
            "study_subtype_code": null,
            "study_population_description": null,
            "study_model_code": null,
            "study_model_other_text": null,
            "sampling_method_code": null,
            "why_study_stopped": null,
            "bio_specimen": {
                "f1": "bio_specimen_description",
                "f2": null,
                "f3": "bio_specimen_retention_code",
                "f4": null
            },
            "primary_purpose": {
                "primary_purpose_code": "TREATMENT",
                "primary_purpose_other_text": null,
                "primary_purpose_additional_qualifier_code": null
            },
            "phase": {
                "phase": "I",
                "phase_other_text": null,
                "phase_additional_qualifier_code": "NO"
            },
            "masking": {
                "masking": null,
                "masking_allocation_code": "Non-Randomized Trial",
                "masking_role_investigator": null,
                "masking_role_outcome_assessor": null,
                "masking_role_subject": null,
                "masking_role_caregiver": null
            },
            "principal_investigator": null,
            "central_contact": {
                "central_contact_email": null,
                "central_contact_name": null,
                "central_contact_phone": null,
                "central_contact_type": null
            },
            "lead_org": "ABM Therapeutics, Inc.",
            "collaborators": null,
            "sites": [
                {
                    "contact_email": "kvan1@mdanderson.org",
                    "contact_name": "Katrien Van Roosbroeck",
                    "contact_phone": "713-792-6044",
                    "recruitment_status": "ACTIVE",
                    "recruitment_status_date": "2020-03-16",
                    "local_site_identifier": "2019-1066",
                    "org_address_line_1": "1515 Holcombe Boulevard",
                    "org_address_line_2": null,
                    "org_city": "Houston",
                    "org_country": "United States",
                    "org_email": "askmdanderson@mdanderson.org",
                    "org_family": "MD Anderson Cancer Center",
                    "org_fax": null,
                    "org_name": "M D Anderson Cancer Center",
                    "org_to_family_relationship": "ORGANIZATIONAL",
                    "org_phone": "877-632-6789",
                    "org_postal_code": "77030",
                    "org_state_or_province": "TX",
                    "org_status": "ACTIVE",
                    "org_status_date": "2019-04-29",
                    "org_tty": null,
                    "org_va": false,
                    "org_coordinates": {
                        "lat": 29.7059,
                        "lon": -95.4026
                    }
                }
            ],
            "anatomic_sites": [
                "Multiple"
            ],
            "diseases": [
                {
                    "inclusion_indicator": "TRIAL",
                    "lead_disease_indicator": "NO",
                    "nci_thesaurus_concept_id": "C3813",
                    "preferred_name": "Metastatic Malignant Neoplasm in the Brain",
                    "display_name": "Metastatic Malignant Neoplasm to the Brain",
                    "paths": [
                        {
                            "direction": 1,
                            "concepts": [
                                {
                                    "idx": 0,
                                    "label": "Central Nervous System Neoplasm",
                                    "code": "C9293"
                                },
                                {
                                    "idx": 1,
                                    "label": "Nervous System Neoplasm",
                                    "code": "C3268"
                                }
                            ]
                        }
                    ],
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Brain Metastases",
                        "Brain Metastasis",
                        "Metast. to brain parenchyma, NOS",
                        "Metastases to brain parenchyma, NOS",
                        "Metastatic Malignant Neoplasm in the Brain",
                        "Metastatic Neoplasm to the Brain",
                        "Metastatic Tumor to the Brain",
                        "brain metastasis"
                    ],
                    "parents": [
                        "C3568",
                        "C4015"
                    ]
                },
                {
                    "inclusion_indicator": "TRIAL",
                    "lead_disease_indicator": "YES",
                    "nci_thesaurus_concept_id": "C127155",
                    "preferred_name": "Metastatic Malignant Solid Neoplasm",
                    "display_name": "Metastatic Malignant Solid Tumor",
                    "paths": [
                        {
                            "direction": 1,
                            "concepts": [
                                {
                                    "idx": 0,
                                    "label": "Solid Neoplasm",
                                    "code": "C9292"
                                }
                            ]
                        }
                    ],
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Metastatic Malignant Solid Neoplasm",
                        "Metastatic Solid Neoplasm",
                        "Metastatic Solid Tumor",
                        "Metastatic Tumor"
                    ],
                    "parents": [
                        "C132146",
                        "C36263"
                    ]
                },
                {
                    "inclusion_indicator": "TRIAL",
                    "lead_disease_indicator": "NO",
                    "nci_thesaurus_concept_id": "C129707",
                    "preferred_name": "Advanced Malignant Solid Neoplasm",
                    "display_name": "Advanced Malignant Solid Tumor",
                    "paths": [
                        {
                            "direction": 1,
                            "concepts": [
                                {
                                    "idx": 0,
                                    "label": "Solid Neoplasm",
                                    "code": "C9292"
                                }
                            ]
                        }
                    ],
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Advanced Malignant Solid Neoplasm",
                        "Advanced Non-Hematologic Malignancy",
                        "Advanced Solid Neoplasm",
                        "Advanced Solid Tumor"
                    ],
                    "parents": [
                        "C9270",
                        "C127155"
                    ]
                },
                {
                    "inclusion_indicator": "TRIAL",
                    "lead_disease_indicator": "YES",
                    "nci_thesaurus_concept_id": "C133093",
                    "preferred_name": "Locally Advanced Malignant Solid Neoplasm",
                    "display_name": "Locally Advanced Malignant Solid Tumor",
                    "paths": [
                        {
                            "direction": 1,
                            "concepts": [
                                {
                                    "idx": 0,
                                    "label": "Solid Neoplasm",
                                    "code": "C9292"
                                }
                            ]
                        }
                    ],
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Locally Advanced Malignant Solid Neoplasm",
                        "Locally Advanced Solid Neoplasm",
                        "Locally Advanced Solid Tumor"
                    ],
                    "parents": [
                        "C8524",
                        "C127155"
                    ]
                },
                {
                    "inclusion_indicator": "TRIAL",
                    "lead_disease_indicator": "NO",
                    "nci_thesaurus_concept_id": "C133737",
                    "preferred_name": "Refractory Malignant Solid Neoplasm",
                    "display_name": "Refractory Malignant Solid Tumor",
                    "paths": [
                        {
                            "direction": 1,
                            "concepts": [
                                {
                                    "idx": 0,
                                    "label": "Solid Neoplasm",
                                    "code": "C9292"
                                }
                            ]
                        }
                    ],
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Refractory Malignant Solid Neoplasm"
                    ],
                    "parents": [
                        "C132146",
                        "C120186"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C8547",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C4788",
                        "C36263"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Metastatic Malignant Neoplasm in the Nervous System",
                    "preferred_name": "Metastatic Malignant Neoplasm in the Nervous System",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Metastases to Nervous System",
                        "Metastasis to the Nervous System",
                        "Metastatic Malignant Neoplasm to the Nervous System",
                        "Metastatic Neoplasm to the Nervous System",
                        "Metastatic Tumor to the Nervous System",
                        "Secondary Malignant Neoplasm to the Nervous System",
                        "Secondary Malignant Tumor to the Nervous System"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C3261",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C7062"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Metastatic Neoplasm",
                    "preferred_name": "Metastatic Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Metastasis",
                        "Metastatic",
                        "Metastatic Disease",
                        "Metastatic Tumor",
                        "Neoplasm, metastatic",
                        "Tumor, metastatic",
                        "metastasis"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C3262",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C2991"
                    ],
                    "lead_disease_indicator": "YES",
                    "display_name": "Other Neoplasm",
                    "preferred_name": "Neoplasm",
                    "type": [
                        "maintype"
                    ],
                    "synonyms": [
                        "Neoplasia",
                        "Neoplasm",
                        "Neoplasm, NOS",
                        "Neoplasms, NOS",
                        "Neoplastic Disease",
                        "Neoplastic Growth",
                        "Tumor, NOS",
                        "neoplasia",
                        "neoplasm",
                        "tumor"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C9292",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C7062"
                    ],
                    "lead_disease_indicator": "YES",
                    "display_name": "Solid Tumor",
                    "preferred_name": "Solid Neoplasm",
                    "type": [
                        "maintype"
                    ],
                    "synonyms": [
                        "Solid Neoplasm",
                        "Solid Tumour",
                        "Solid tumor, NOS",
                        "solid tumor"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C4627",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C9293",
                        "C4788"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Malignant Central Nervous System Neoplasm",
                    "preferred_name": "Malignant Central Nervous System Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "CNS Cancer",
                        "CNS Malignant Neoplasms",
                        "CNS Neoplasms, Malignant",
                        "Cancer of CNS",
                        "Cancer of Central Nervous System",
                        "Cancer of the CNS",
                        "Cancer of the Central Nervous System",
                        "Central Nervous System Cancer",
                        "Central Nervous System Neoplasms, Malignant",
                        "Malignant CNS Neoplasm",
                        "Malignant CNS Neoplasms",
                        "Malignant CNS Tumor",
                        "Malignant Central Nervous System Tumor",
                        "Malignant Neoplasm of CNS",
                        "Malignant Neoplasm of Central Nervous System",
                        "Malignant Neoplasm of the CNS",
                        "Malignant Neoplasm of the Central Nervous System",
                        "Malignant Tumor of CNS",
                        "Malignant Tumor of Central Nervous System",
                        "Malignant Tumor of the CNS",
                        "Malignant Tumor of the Central Nervous System"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C36263",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C3261",
                        "C4968"
                    ],
                    "lead_disease_indicator": "YES",
                    "display_name": "Metastatic Malignant Neoplasm",
                    "preferred_name": "Metastatic Malignant Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Metastatic Cancer"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C2907",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C96413",
                        "C4953"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Brain Tumor",
                    "preferred_name": "Brain Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Brain Neoplasm",
                        "Brain Neoplasms",
                        "Neoplasm of Brain",
                        "Neoplasm of the Brain",
                        "Tumor of Brain",
                        "Tumor of the Brain",
                        "brain tumor"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C3268",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C3263",
                        "C26835"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Nervous System Tumor",
                    "preferred_name": "Nervous System Neoplasm",
                    "type": [
                        "maintype"
                    ],
                    "synonyms": [
                        "Neoplasm of Nervous System",
                        "Neoplasm of the Nervous System",
                        "Nervous System Neoplasm",
                        "Nervous System Neoplasms",
                        "Nervous System Tumour",
                        "Tumor of Nervous System",
                        "Tumor of the Nervous System"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C9292",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C7062"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Solid Tumor",
                    "preferred_name": "Solid Neoplasm",
                    "type": [
                        "maintype"
                    ],
                    "synonyms": [
                        "Solid Neoplasm",
                        "Solid Tumour",
                        "Solid tumor, NOS",
                        "solid tumor"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C127155",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C132146",
                        "C36263"
                    ],
                    "lead_disease_indicator": "YES",
                    "display_name": "Metastatic Malignant Solid Tumor",
                    "preferred_name": "Metastatic Malignant Solid Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Metastatic Malignant Solid Neoplasm",
                        "Metastatic Solid Neoplasm",
                        "Metastatic Solid Tumor",
                        "Metastatic Tumor"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C7062",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C3262"
                    ],
                    "lead_disease_indicator": "YES",
                    "display_name": "Neoplasm by Special Category",
                    "preferred_name": "Neoplasm by Special Category",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": []
                },
                {
                    "nci_thesaurus_concept_id": "C132146",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C9305",
                        "C9292"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Malignant Solid Tumor",
                    "preferred_name": "Malignant Solid Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Malignant Solid Neoplasm"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C26835",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C27551"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Nervous System Disorder",
                    "preferred_name": "Nervous System Disorder",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Disorder of Nervous System",
                        "Neurologic Disorder",
                        "Neurological Disorder",
                        "Unspecified Nervous System Problem"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C2991",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C7057"
                    ],
                    "lead_disease_indicator": "YES",
                    "display_name": "Other Disease",
                    "preferred_name": "Disease or Disorder",
                    "type": [
                        "maintype"
                    ],
                    "synonyms": [
                        "Diagnosis",
                        "Disease",
                        "Disease or Disorder",
                        "Disease or Disorder, Non-Neoplastic",
                        "Diseases",
                        "Diseases and Disorders",
                        "Disorder",
                        "Disorders",
                        "condition",
                        "disease",
                        "disease term",
                        "disease type",
                        "disease_term",
                        "disease_type",
                        "disorder"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C2934",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C26835"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Central Nervous System Disorder",
                    "preferred_name": "Central Nervous System Disorder",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Central Nervous System Disease",
                        "Disorder of Central Nervous System"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C96413",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C2934"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Brain Disorder",
                    "preferred_name": "Brain Disorder",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": []
                },
                {
                    "nci_thesaurus_concept_id": "C7057",
                    "inclusion_indicator": "TREE",
                    "parents": [],
                    "lead_disease_indicator": "NO",
                    "display_name": "Disease, Disorder or Finding",
                    "preferred_name": "Disease, Disorder or Finding",
                    "type": [],
                    "synonyms": []
                },
                {
                    "nci_thesaurus_concept_id": "C7062",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C3262"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Neoplasm by Special Category",
                    "preferred_name": "Neoplasm by Special Category",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": []
                },
                {
                    "nci_thesaurus_concept_id": "C36263",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C3261",
                        "C4968"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Metastatic Malignant Neoplasm",
                    "preferred_name": "Metastatic Malignant Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Metastatic Cancer"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C9305",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C7062"
                    ],
                    "lead_disease_indicator": "YES",
                    "display_name": "Malignant Neoplasm",
                    "preferred_name": "Malignant Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "CA",
                        "Cancer",
                        "Malignancy",
                        "Malignant Growth",
                        "Malignant Neoplastic Disease",
                        "Malignant Tumor",
                        "NEOPLASM, MALIGNANT",
                        "Neoplasm, malignant",
                        "Tumor, malignant, NOS",
                        "Unclassified tumor, malignant",
                        "cancer",
                        "malignancy"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C3261",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C7062"
                    ],
                    "lead_disease_indicator": "YES",
                    "display_name": "Metastatic Neoplasm",
                    "preferred_name": "Metastatic Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Metastasis",
                        "Metastatic",
                        "Metastatic Disease",
                        "Metastatic Tumor",
                        "Neoplasm, metastatic",
                        "Tumor, metastatic",
                        "metastasis"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C3568",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C2907",
                        "C5114"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Malignant Brain Tumor",
                    "preferred_name": "Malignant Brain Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Brain Cancer",
                        "Brain Neoplasms, Malignant",
                        "Cancer of Brain",
                        "Cancer of the Brain",
                        "Malignant Brain Neoplasm",
                        "Malignant Neoplasm of Brain",
                        "Malignant Neoplasm of the Brain",
                        "Malignant Tumor of Brain",
                        "Malignant Tumor of the Brain"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C7628",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C7062"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Refractory Neoplasm",
                    "preferred_name": "Refractory Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Refractory Tumor"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C5114",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C4953",
                        "C4627"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Malignant Intracranial Neoplasm",
                    "preferred_name": "Malignant Intracranial Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Intracranial Cancer",
                        "Intracranial Neoplasms, Malignant",
                        "Intracranial Tumors, Malignant",
                        "Malignant Intracranial Tumor"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C9305",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C7062"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Malignant Neoplasm",
                    "preferred_name": "Malignant Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "CA",
                        "Cancer",
                        "Malignancy",
                        "Malignant Growth",
                        "Malignant Neoplastic Disease",
                        "Malignant Tumor",
                        "NEOPLASM, MALIGNANT",
                        "Neoplasm, malignant",
                        "Tumor, malignant, NOS",
                        "Unclassified tumor, malignant",
                        "cancer",
                        "malignancy"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C3263",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C3262"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Neoplasm by Site",
                    "preferred_name": "Neoplasm by Site",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": []
                },
                {
                    "nci_thesaurus_concept_id": "C4968",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C9305",
                        "C36255"
                    ],
                    "lead_disease_indicator": "YES",
                    "display_name": "Secondary Malignant Neoplasm",
                    "preferred_name": "Secondary Malignant Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Development of SMN",
                        "Development of Secondary Malignancy Neoplasm",
                        "Secondary Cancer",
                        "Secondary Malignancy",
                        "secondary cancer"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C127155",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C132146",
                        "C36263"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Metastatic Malignant Solid Tumor",
                    "preferred_name": "Metastatic Malignant Solid Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Metastatic Malignant Solid Neoplasm",
                        "Metastatic Solid Neoplasm",
                        "Metastatic Solid Tumor",
                        "Metastatic Tumor"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C132146",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C9305",
                        "C9292"
                    ],
                    "lead_disease_indicator": "YES",
                    "display_name": "Malignant Solid Tumor",
                    "preferred_name": "Malignant Solid Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Malignant Solid Neoplasm"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C27551",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C2991"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Disorder by Site",
                    "preferred_name": "Disorder by Site",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Disease by Site"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C2991",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C7057"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Other Disease",
                    "preferred_name": "Disease or Disorder",
                    "type": [
                        "maintype"
                    ],
                    "synonyms": [
                        "Diagnosis",
                        "Disease",
                        "Disease or Disorder",
                        "Disease or Disorder, Non-Neoplastic",
                        "Diseases",
                        "Diseases and Disorders",
                        "Disorder",
                        "Disorders",
                        "condition",
                        "disease",
                        "disease term",
                        "disease type",
                        "disease_term",
                        "disease_type",
                        "disorder"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C36255",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C7062"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Secondary Neoplasm",
                    "preferred_name": "Secondary Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Neoplasm, secondary",
                        "Secondary Tumor",
                        "Tumor, secondary",
                        "secondary tumor"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C9270",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C36263"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Advanced Malignant Neoplasm",
                    "preferred_name": "Advanced Malignant Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Advanced Cancer",
                        "advanced cancer"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C9293",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C2934",
                        "C3268"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Brain/Spinal Cord Tumor",
                    "preferred_name": "Central Nervous System Neoplasm",
                    "type": [
                        "maintype",
                        "subtype"
                    ],
                    "synonyms": [
                        "CNS Neoplasm",
                        "CNS Tumor",
                        "CNS tumor",
                        "Central Nervous System Neoplasm",
                        "Central Nervous System Tumor",
                        "Neoplasm of CNS",
                        "Neoplasm of Central Nervous System",
                        "Neoplasm of the Central Nervous System",
                        "Tumor of CNS",
                        "Tumor of Central Nervous System",
                        "Tumor of the CNS",
                        "Tumor of the Central Nervous System",
                        "central nervous system tumor"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C120186",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C9305",
                        "C7628"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Refractory Malignant Neoplasm",
                    "preferred_name": "Refractory Malignant Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Refractory Cancer",
                        "clinical resistance",
                        "refractory cancer",
                        "resistant cancer"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C3262",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C2991"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Other Neoplasm",
                    "preferred_name": "Neoplasm",
                    "type": [
                        "maintype"
                    ],
                    "synonyms": [
                        "Neoplasia",
                        "Neoplasm",
                        "Neoplasm, NOS",
                        "Neoplasms, NOS",
                        "Neoplastic Disease",
                        "Neoplastic Growth",
                        "Tumor, NOS",
                        "neoplasia",
                        "neoplasm",
                        "tumor"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C7057",
                    "inclusion_indicator": "TREE",
                    "parents": [],
                    "lead_disease_indicator": "YES",
                    "display_name": "Disease, Disorder or Finding",
                    "preferred_name": "Disease, Disorder or Finding",
                    "type": [],
                    "synonyms": []
                },
                {
                    "nci_thesaurus_concept_id": "C4968",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C9305",
                        "C36255"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Secondary Malignant Neoplasm",
                    "preferred_name": "Secondary Malignant Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Development of SMN",
                        "Development of Secondary Malignancy Neoplasm",
                        "Secondary Cancer",
                        "Secondary Malignancy",
                        "secondary cancer"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C36255",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C7062"
                    ],
                    "lead_disease_indicator": "YES",
                    "display_name": "Secondary Neoplasm",
                    "preferred_name": "Secondary Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Neoplasm, secondary",
                        "Secondary Tumor",
                        "Tumor, secondary",
                        "secondary tumor"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C4015",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C4627",
                        "C8547"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Metastatic Malignant Neoplasm to the Central Nervous System",
                    "preferred_name": "Metastatic Malignant Neoplasm in the Central Nervous System",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "CNS Metastases",
                        "CNS Metastasis",
                        "CNS metastasis",
                        "Central Nervous System Metastases",
                        "Central Nervous System Metastasis",
                        "Metastatic Malignant Neoplasm in the Central Nervous System",
                        "Metastatic Neoplasm to the CNS",
                        "Metastatic Neoplasm to the Central Nervous System",
                        "Metastatic Tumor to the CNS",
                        "Metastatic Tumor to the Central Nervous System",
                        "central nervous system metastasis"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C4953",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C9293"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Intracranial Neoplasm",
                    "preferred_name": "Intracranial Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Intracranial Central Nervous System Neoplasm",
                        "Intracranial Central Nervous System Tumor",
                        "Intracranial Tumor",
                        "intracranial tumor"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C8524",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C36263"
                    ],
                    "lead_disease_indicator": "YES",
                    "display_name": "Locally Advanced Malignant Neoplasm",
                    "preferred_name": "Locally Advanced Malignant Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Locally Advanced Cancer",
                        "Locally Metastatic Malignant Neoplasm",
                        "Locally advanced",
                        "locally advanced cancer",
                        "regional cancer"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C4788",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C9305",
                        "C3268"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Malignant Nervous System Neoplasm",
                    "preferred_name": "Malignant Nervous System Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Malignant Neoplasm of Nervous System",
                        "Malignant Neoplasm of the Nervous System",
                        "Malignant Nervous System Tumor",
                        "Malignant Tumor of Nervous System",
                        "Malignant Tumor of the Nervous System",
                        "Nervous System Neoplasms, Malignant"
                    ]
                }
            ],
            "biomarkers": [
                {
                    "assay_purpose": "Eligibility Criterion - Inclusion",
                    "long_name": "BRAF V600 Protein Variation",
                    "name": "BRAF V600 Mutation",
                    "synonyms": [
                        "BRAF NP_004324.2:p.V600 Mutation",
                        "BRAF NP_004324.2:p.V600X",
                        "BRAF NP_004324.2:p.Val600 Mutation",
                        "BRAF NP_004324.2:p.Val600Xxx",
                        "NP_004324.2:p.Val600 Mutation",
                        "Serine/Threonine-Protein Kinase B-raf Protein Val600 Mutation",
                        "BRAF p.V600 Mutation",
                        "Serine/Threonine-Protein Kinase B-raf Protein Val600Xxx",
                        "BRAF p.V600X",
                        "BRAF V600X",
                        "BRAF p.Val600 Mutation",
                        "BRAF p.Val600Xxx",
                        "NP_004324.2:p.V600 Mutation",
                        "NP_004324.2:p.V600X",
                        "NP_004324.2:p.Val600Xxx",
                        "Serine/Threonine-Protein Kinase B-raf Protein V600X",
                        "Serine/Threonine-Protein Kinase B-raf Protein V600 Mutation",
                        "Serine/Threonine-Protein Kinase B-raf Protein V600 Protein Variation"
                    ],
                    "hugo_biomarker_code": null,
                    "nci_thesaurus_concept_id": "C105823",
                    "eligibility_criterion": "inclusion"
                },
                {
                    "assay_purpose": "Eligibility Criterion - Inclusion",
                    "long_name": "BRAF NP_004324.2:p.V600E",
                    "name": "BRAF V600E Mutation",
                    "synonyms": [
                        "Serine/Threonine-Protein Kinase B-raf Val600Glu",
                        "BRAF V600E Activating Mutation",
                        "BRAF NP_004324.2:p.Val600Glu",
                        "BRAF V600E",
                        "BRAF p.V600E",
                        "Activating BRAF V600E Mutation",
                        "NP_004324.2:p.V600E",
                        "BRAF p.Val600Glu",
                        "Serine/Threonine-Protein Kinase B-raf V600E",
                        "NP_004324.2:p.Val600Glu",
                        "BRAF V600E Mutation",
                        "BRAF Val600Glu"
                    ],
                    "hugo_biomarker_code": null,
                    "nci_thesaurus_concept_id": "C98342",
                    "eligibility_criterion": "inclusion"
                }
            ],
            "minimum_target_accrual_number": 27,
            "eligibility": {
                "structured": {
                    "gender": "BOTH",
                    "max_age": "999 Years",
                    "max_age_number": 999,
                    "max_age_unit": "Years",
                    "min_age": "18 Years",
                    "min_age_number": 18,
                    "min_age_unit": "Years",
                    "max_age_in_years": 999,
                    "min_age_in_years": 18
                },
                "unstructured": [
                    {
                        "display_order": 0,
                        "inclusion_indicator": true,
                        "description": "Male and female subjects age 18 years and older who are able to sign informed consent and to comply with the protocol"
                    },
                    {
                        "display_order": 1,
                        "inclusion_indicator": true,
                        "description": "Patients with histologically or cytologically-documented, locally advanced, or metastatic solid malignancy that has either (a) failed prior standard therapy, (b) for which no standard therapy exists, or (c) standard therapy is not considered appropriate by the patient or treating physician. There is no limit to the number of prior treatment regimens."
                    },
                    {
                        "display_order": 2,
                        "inclusion_indicator": true,
                        "description": "Documentation of positive BRAF V600E mutation, or any other B-Raf V600 mutation is required for enrollment."
                    },
                    {
                        "display_order": 3,
                        "inclusion_indicator": true,
                        "description": "Patients with stable brain metastasis or with active brain metastasis that are asymptomatic, or that are symptomatic but requiring a stable or decreasing dose of steroids for at least 2 weeks, are allowed for enrollment. (Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology- Friends of Cancer Research Brain Metastases Working Group 2017)."
                    },
                    {
                        "display_order": 4,
                        "inclusion_indicator": true,
                        "description": "Active, symptomatic brain metastasis: patients with nerologic signs and symptoms may be treated with a total daily dose of no more than 4 mg of dexamethasone (or equivalent) that is stable or tapering for at least 2 weeks prior to first treatment. Patients with neurologic signs and symptoms who are not being treated with steroids are eligible and should have no experience of seizure within 2 weeks prior to first treatment. ECOG performance status of 2 will be allowed in the RP2D Dose Confirmation Cohort."
                    },
                    {
                        "display_order": 5,
                        "inclusion_indicator": true,
                        "description": "Must have at least one measurable lesion as defined by RECIST V1.1 criteria for solid tumors"
                    },
                    {
                        "display_order": 6,
                        "inclusion_indicator": true,
                        "description": "Measurable brain lesions that are 0.5 - 3 cm in longest diameter as defined by the modified RECIST V1.1 criteria (Appendix A) are allowed."
                    },
                    {
                        "display_order": 7,
                        "inclusion_indicator": true,
                        "description": "Brain lesion size > 3 cm is not eligible."
                    },
                    {
                        "display_order": 8,
                        "inclusion_indicator": true,
                        "description": "ECOG performance status of 0 or 1"
                    },
                    {
                        "display_order": 9,
                        "inclusion_indicator": true,
                        "description": "Adequate organ function confirmed at screening and within 28 days of initiating treatment, as evidenced by:"
                    },
                    {
                        "display_order": 10,
                        "inclusion_indicator": true,
                        "description": "Absolute Neutrophil Count (ANC)  1.0 x 10^9/L"
                    },
                    {
                        "display_order": 11,
                        "inclusion_indicator": true,
                        "description": "Hemoglobin (Hgb)  9 g/dl"
                    },
                    {
                        "display_order": 12,
                        "inclusion_indicator": true,
                        "description": "Platelets (Plt)  100 x 10^9/L"
                    },
                    {
                        "display_order": 13,
                        "inclusion_indicator": true,
                        "description": "AST/ALT  2.5 x Upper Limit of Normal (ULN) or  5.0 x ULN if liver metastases are present"
                    },
                    {
                        "display_order": 14,
                        "inclusion_indicator": true,
                        "description": "Total bilirubin  1.5 x ULN, or direct bilirubin <ULN for patients with total bilirubin levels >1.5 ULN"
                    },
                    {
                        "display_order": 15,
                        "inclusion_indicator": true,
                        "description": "Serum creatinine <1.5 x ULN or measured or calculated (per institutional standard) creatinine clearance of > 60 mL/min."
                    },
                    {
                        "display_order": 16,
                        "inclusion_indicator": true,
                        "description": "Negative pregnancy test within 72 hours before starting study treatment in all pre-menopausal women and women <12 months after the onset of menopause"
                    },
                    {
                        "display_order": 17,
                        "inclusion_indicator": true,
                        "description": "Male and female subjects must agree to take sufficient contraceptive methods to avoid pregnancy before first dose of study treatment, during the study, and for at least 60 days after ceasing study treatment"
                    },
                    {
                        "display_order": 18,
                        "inclusion_indicator": false,
                        "description": "Women who are pregnant or breast-feeding"
                    },
                    {
                        "display_order": 19,
                        "inclusion_indicator": false,
                        "description": "Women of child-bearing potential (WOCBP) who does not use adequate birth control"
                    },
                    {
                        "display_order": 20,
                        "inclusion_indicator": false,
                        "description": "Patients with any hematologic malignancy. This includes leukemia (any form), lymphoma, and multiple myeloma"
                    },
                    {
                        "display_order": 21,
                        "inclusion_indicator": false,
                        "description": "Have a second primary malignancy that, in the judgment of the investigator, may affect the interpretation of results"
                    },
                    {
                        "display_order": 22,
                        "inclusion_indicator": false,
                        "description": "Patients with carcinomatous meningitis (leptomeningeal disease (LMD))"
                    },
                    {
                        "display_order": 23,
                        "inclusion_indicator": false,
                        "description": "Patients with history of stroke  6 months prior to starting study drug"
                    },
                    {
                        "display_order": 24,
                        "inclusion_indicator": false,
                        "description": "Patients who have had an experience of seizure within 14 days prior to first treatment"
                    },
                    {
                        "display_order": 25,
                        "inclusion_indicator": false,
                        "description": "Impaired cardiac function or clinically significant cardiac diseases, including but not limited to any of the following:"
                    },
                    {
                        "display_order": 26,
                        "inclusion_indicator": false,
                        "description": "Left Ventricular Ejection Fraction (LVEF) < 45% as determined by MUGA scan or ECHO"
                    },
                    {
                        "display_order": 27,
                        "inclusion_indicator": false,
                        "description": "Congenital long QT syndrome"
                    },
                    {
                        "display_order": 28,
                        "inclusion_indicator": false,
                        "description": "QTcF  450 msec (mean) on screening (Triplicate 12-Lead ECG)"
                    },
                    {
                        "display_order": 29,
                        "inclusion_indicator": false,
                        "description": "Unstable angina pectoris  6 months prior to starting study drug"
                    },
                    {
                        "display_order": 30,
                        "inclusion_indicator": false,
                        "description": "Acute myocardial infarction  6 months prior to starting study drug"
                    },
                    {
                        "display_order": 31,
                        "inclusion_indicator": false,
                        "description": "Use of pacemaker"
                    },
                    {
                        "display_order": 32,
                        "inclusion_indicator": false,
                        "description": "Patients with"
                    },
                    {
                        "display_order": 33,
                        "inclusion_indicator": false,
                        "description": "Unresolved diarrhea  CTCAE Grade 2, or"
                    },
                    {
                        "display_order": 34,
                        "inclusion_indicator": false,
                        "description": "Impairment of gastrointestinal (GI) function, or"
                    },
                    {
                        "display_order": 35,
                        "inclusion_indicator": false,
                        "description": "GI disease or conditions that may significantly alter the absorption of ABM-1310 (e.g., ulcerative diseases, uncontrolled nausea, vomiting, diarrhea, malabsorption syndrome, or small bowel resection)"
                    },
                    {
                        "display_order": 36,
                        "inclusion_indicator": false,
                        "description": "Other concurrent severe and/or uncontrolled concomitant medical conditions (e.g., uncontrolled hypertriglyceridemia [triglycerides >500 mg/dL], active or uncontrolled infection) that could cause unacceptable safety risks or compromise compliance with the protocol"
                    },
                    {
                        "display_order": 37,
                        "inclusion_indicator": false,
                        "description": "Extensive prior radiotherapy to more than 30% of bone marrow reserves, or prior bone marrow/stem cell transplantation within 5 years"
                    },
                    {
                        "display_order": 38,
                        "inclusion_indicator": false,
                        "description": "Patients who have received chemotherapy, targeted therapy or immunotherapy  4 weeks prior to starting study drug or who have not recovered from side effects of such therapy, except:"
                    },
                    {
                        "display_order": 39,
                        "inclusion_indicator": false,
                        "description": " 6 weeks for nitrosourea or mitomycin-C"
                    },
                    {
                        "display_order": 40,
                        "inclusion_indicator": false,
                        "description": " 5 half-lives or 2 weeks for FDA approved BRAF and MEK inhibitor treatment, whichever is shorter"
                    },
                    {
                        "display_order": 41,
                        "inclusion_indicator": false,
                        "description": "Patients who have received wide field radiotherapy  4 weeks or limited field radiation for palliation  2 weeks, prior whole-brain radiotherapy (WBRT)  4 weeks or stereotactic radiosurgery (SRS)  2 weeks prior to starting study drug or patietns who have not recovered from side effects of such therapy"
                    },
                    {
                        "display_order": 42,
                        "inclusion_indicator": false,
                        "description": "Patients who have undergone major surgery  2 weeks prior to starting study drug or who have not recovered from side effects of such therapy"
                    },
                    {
                        "display_order": 43,
                        "inclusion_indicator": false,
                        "description": "Patients who are currently receiving treatment with therapeutic doses of warfarin sodium or any other coumarin-derivative anticoagulants"
                    },
                    {
                        "display_order": 44,
                        "inclusion_indicator": false,
                        "description": "Patients who have received systemic corticosteroids  2 weeks prior to starting study drug or who have not recovered from the side effects of such treatment Note: Patients that are taking replacement doses of steroids are eligible"
                    },
                    {
                        "display_order": 45,
                        "inclusion_indicator": false,
                        "description": "Patients who are currently receiving treatment with medication that has known risk to prolong the QT interval, and the treatment cannot either be discontinued or switched to a different medication prior to starting study drug"
                    },
                    {
                        "display_order": 46,
                        "inclusion_indicator": false,
                        "description": "Known diagnosis of human immunodeficiency virus (HIV) infection (HIV testing is not mandatory; patients with well controlled HIV might be enrolled per investigator's discretion)"
                    },
                    {
                        "display_order": 47,
                        "inclusion_indicator": false,
                        "description": "Known history of active infection with Hepatitis B (e.g., HBsAg reactive), or Hepatitis C (e.g., HCV RNA (qualitative) is detected)"
                    },
                    {
                        "display_order": 48,
                        "inclusion_indicator": false,
                        "description": "History of alcohol or drug abuse  3 months prior to first dose"
                    },
                    {
                        "display_order": 49,
                        "inclusion_indicator": false,
                        "description": "Has a history or current evidence of any condition, therapy, or laboratory abnormality that, in the opinion of the investigator, might confound the results of the trial, interfere with the patient's participation and compliance in the trial"
                    }
                ]
            },
            "number_of_arms": 2,
            "arms": [
                {
                    "arm_name": "Arm not specified",
                    "arm_type": null,
                    "arm_description": null,
                    "interventions": [
                        {
                            "intervention_name": "BRAF(V600E) Kinase Inhibitor ABM-1310",
                            "intervention_type": "Drug",
                            "intervention_code": "C170951",
                            "intervention_description": null,
                            "parents": [
                                "C129825",
                                "C155322"
                            ],
                            "inclusion_indicator": "TRIAL",
                            "synonyms": [],
                            "intervention_category": "Agent"
                        },
                        {
                            "intervention_code": "C129825",
                            "intervention_name": "Antineoplastic Enzyme Inhibitor",
                            "inclusion_indicator": "TREE",
                            "intervention_type": "Drug",
                            "intervention_description": "",
                            "intervention_category": "Agent Category",
                            "parents": [
                                "C129824",
                                "C471"
                            ],
                            "synonyms": [
                                "Anti-cancer Enzyme Inhibitor"
                            ]
                        },
                        {
                            "intervention_code": "C129824",
                            "intervention_name": "Antineoplastic Protein Inhibitor",
                            "inclusion_indicator": "TREE",
                            "intervention_type": "Drug",
                            "intervention_description": "",
                            "intervention_category": "Agent Category",
                            "parents": [
                                "C2189"
                            ],
                            "synonyms": [
                                "Anti-cancer Protein Inhibitor",
                                "Antineoplastic Protein Antagonist"
                            ]
                        },
                        {
                            "intervention_code": "C2189",
                            "intervention_name": "Signal Transduction Inhibitor",
                            "inclusion_indicator": "TREE",
                            "intervention_type": "Drug",
                            "intervention_description": "",
                            "intervention_category": "Agent Category",
                            "parents": [
                                "C274"
                            ],
                            "synonyms": []
                        },
                        {
                            "intervention_code": "C274",
                            "intervention_name": "Antineoplastic Agent",
                            "inclusion_indicator": "TREE",
                            "intervention_type": "Drug",
                            "intervention_description": "",
                            "intervention_category": "Agent Category",
                            "parents": [
                                "C1909"
                            ],
                            "synonyms": [
                                "Anti-Cancer Agents",
                                "Anti-Tumor Agents",
                                "Anti-Tumor Drugs",
                                "Antineoplastic Drugs",
                                "Antineoplastics",
                                "Antiproliferative Agents",
                                "Antiproliferative Drugs",
                                "Cancer Drug",
                                "Chemotherapeutic Agents, Neoplastic Disease",
                                "Tumor-Specific Treatment Agents"
                            ]
                        },
                        {
                            "intervention_code": "C1909",
                            "intervention_name": "Pharmacologic Substance",
                            "inclusion_indicator": "TREE",
                            "intervention_type": "Drug",
                            "intervention_description": "",
                            "intervention_category": "Agent Category",
                            "parents": [
                                "C1908"
                            ],
                            "synonyms": [
                                "Agent",
                                "Drug",
                                "Drug Substance",
                                "Pharmaceutical Agent",
                                "Pharmaceuticals",
                                "Pharmacologic Agent",
                                "Pharmacological Substance"
                            ]
                        },
                        {
                            "intervention_code": "C1908",
                            "intervention_name": "Drug, Food, Chemical or Biomedical Material",
                            "inclusion_indicator": "TREE",
                            "intervention_type": "Drug",
                            "intervention_description": "",
                            "intervention_category": "Agent Category",
                            "parents": [],
                            "synonyms": []
                        },
                        {
                            "intervention_code": "C471",
                            "intervention_name": "Enzyme Inhibitor",
                            "inclusion_indicator": "TREE",
                            "intervention_type": "Drug",
                            "intervention_description": "",
                            "intervention_category": "Agent Category",
                            "parents": [
                                "C1909"
                            ],
                            "synonyms": [
                                "Enzyme Antagonist",
                                "Enzyme Inhibitor Agent",
                                "Enzyme Inhibitor Drug"
                            ]
                        },
                        {
                            "intervention_code": "C155322",
                            "intervention_name": "BRAF Inhibitor",
                            "inclusion_indicator": "TREE",
                            "intervention_type": "Drug",
                            "intervention_description": "",
                            "intervention_category": "Agent Category",
                            "parents": [
                                "C2336"
                            ],
                            "synonyms": [
                                "B-RAF Inhibitor"
                            ]
                        },
                        {
                            "intervention_code": "C2336",
                            "intervention_name": "Raf Kinase Inhibitor",
                            "inclusion_indicator": "TREE",
                            "intervention_type": "Drug",
                            "intervention_description": "",
                            "intervention_category": "Agent Category",
                            "parents": [
                                "C61074",
                                "C163758"
                            ],
                            "synonyms": []
                        },
                        {
                            "intervention_code": "C61074",
                            "intervention_name": "Serine/Threonine Kinase Inhibitor",
                            "inclusion_indicator": "TREE",
                            "intervention_type": "Drug",
                            "intervention_description": "",
                            "intervention_category": "Agent Category",
                            "parents": [
                                "C1404"
                            ],
                            "synonyms": []
                        },
                        {
                            "intervention_code": "C1404",
                            "intervention_name": "Protein Kinase Inhibitor",
                            "inclusion_indicator": "TREE",
                            "intervention_type": "Drug",
                            "intervention_description": "",
                            "intervention_category": "Agent Category",
                            "parents": [
                                "C471"
                            ],
                            "synonyms": []
                        },
                        {
                            "intervention_code": "C163758",
                            "intervention_name": "Targeted Therapy Agent",
                            "inclusion_indicator": "TREE",
                            "intervention_type": "Drug",
                            "intervention_description": "",
                            "intervention_category": "Agent Category",
                            "parents": [
                                "C274"
                            ],
                            "synonyms": [
                                "Anti-tumor Targeted Therapy Agent",
                                "Molecularly Targeted Therapy Agent",
                                "Targeted Agent",
                                "Targeted Therapeutic Agent"
                            ]
                        }
                    ]
                },
                {
                    "arm_name": "Dose Escalation",
                    "arm_type": "EXPERIMENTAL",
                    "arm_description": "A classic \"3+3\" design will be used to determine MTD and RP2D. Three to six patients per treatment cohort will be assigned to receive sequentially higher oral doses of ABM-1310 on a twice daily schedule (bid) for 28-day cycles, starting at a dose of 25 mg bid. Patients will receive twice daily oral doses of ABM-1310 until disease progression, unacceptable toxicity, or a clinical observation satisfying another withdrawal criterion is met.",
                    "interventions": []
                },
                {
                    "arm_name": "MTD/RP2D Confirmation",
                    "arm_type": "EXPERIMENTAL",
                    "arm_description": "Patients will receive twice daily oral doses of ABM-1310 in 28-day treatment cycles until disease progression, unacceptable toxicity, or another withdrawal criterion is met.",
                    "interventions": []
                },
                {
                    "arm_name": "Study does not have any arms",
                    "arm_type": null,
                    "arm_description": null,
                    "interventions": [
                        {
                            "intervention_name": "BRAF(V600E) Kinase Inhibitor ABM-1310",
                            "intervention_type": "Drug",
                            "intervention_code": "C170951",
                            "intervention_description": null,
                            "inclusion_indicator": "TRIAL",
                            "synonyms": [],
                            "intervention_category": "Agent",
                            "parents": [
                                "C129825",
                                "C155322"
                            ]
                        },
                        {
                            "intervention_code": "C129825",
                            "intervention_name": "Antineoplastic Enzyme Inhibitor",
                            "inclusion_indicator": "TREE",
                            "intervention_type": "Drug",
                            "intervention_description": "",
                            "intervention_category": "Agent Category",
                            "parents": [
                                "C129824",
                                "C471"
                            ],
                            "synonyms": [
                                "Anti-cancer Enzyme Inhibitor"
                            ]
                        },
                        {
                            "intervention_code": "C129824",
                            "intervention_name": "Antineoplastic Protein Inhibitor",
                            "inclusion_indicator": "TREE",
                            "intervention_type": "Drug",
                            "intervention_description": "",
                            "intervention_category": "Agent Category",
                            "parents": [
                                "C2189"
                            ],
                            "synonyms": [
                                "Anti-cancer Protein Inhibitor",
                                "Antineoplastic Protein Antagonist"
                            ]
                        },
                        {
                            "intervention_code": "C2189",
                            "intervention_name": "Signal Transduction Inhibitor",
                            "inclusion_indicator": "TREE",
                            "intervention_type": "Drug",
                            "intervention_description": "",
                            "intervention_category": "Agent Category",
                            "parents": [
                                "C274"
                            ],
                            "synonyms": []
                        },
                        {
                            "intervention_code": "C274",
                            "intervention_name": "Antineoplastic Agent",
                            "inclusion_indicator": "TREE",
                            "intervention_type": "Drug",
                            "intervention_description": "",
                            "intervention_category": "Agent Category",
                            "parents": [
                                "C1909"
                            ],
                            "synonyms": [
                                "Anti-Cancer Agents",
                                "Anti-Tumor Agents",
                                "Anti-Tumor Drugs",
                                "Antineoplastic Drugs",
                                "Antineoplastics",
                                "Antiproliferative Agents",
                                "Antiproliferative Drugs",
                                "Cancer Drug",
                                "Chemotherapeutic Agents, Neoplastic Disease",
                                "Tumor-Specific Treatment Agents"
                            ]
                        },
                        {
                            "intervention_code": "C1909",
                            "intervention_name": "Pharmacologic Substance",
                            "inclusion_indicator": "TREE",
                            "intervention_type": "Drug",
                            "intervention_description": "",
                            "intervention_category": "Agent Category",
                            "parents": [
                                "C1908"
                            ],
                            "synonyms": [
                                "Agent",
                                "Drug",
                                "Drug Substance",
                                "Pharmaceutical Agent",
                                "Pharmaceuticals",
                                "Pharmacologic Agent",
                                "Pharmacological Substance"
                            ]
                        },
                        {
                            "intervention_code": "C1908",
                            "intervention_name": "Drug, Food, Chemical or Biomedical Material",
                            "inclusion_indicator": "TREE",
                            "intervention_type": "Drug",
                            "intervention_description": "",
                            "intervention_category": "Agent Category",
                            "parents": [],
                            "synonyms": []
                        },
                        {
                            "intervention_code": "C471",
                            "intervention_name": "Enzyme Inhibitor",
                            "inclusion_indicator": "TREE",
                            "intervention_type": "Drug",
                            "intervention_description": "",
                            "intervention_category": "Agent Category",
                            "parents": [
                                "C1909"
                            ],
                            "synonyms": [
                                "Enzyme Antagonist",
                                "Enzyme Inhibitor Agent",
                                "Enzyme Inhibitor Drug"
                            ]
                        },
                        {
                            "intervention_code": "C155322",
                            "intervention_name": "BRAF Inhibitor",
                            "inclusion_indicator": "TREE",
                            "intervention_type": "Drug",
                            "intervention_description": "",
                            "intervention_category": "Agent Category",
                            "parents": [
                                "C2336"
                            ],
                            "synonyms": [
                                "B-RAF Inhibitor"
                            ]
                        },
                        {
                            "intervention_code": "C2336",
                            "intervention_name": "Raf Kinase Inhibitor",
                            "inclusion_indicator": "TREE",
                            "intervention_type": "Drug",
                            "intervention_description": "",
                            "intervention_category": "Agent Category",
                            "parents": [
                                "C61074",
                                "C163758"
                            ],
                            "synonyms": []
                        },
                        {
                            "intervention_code": "C61074",
                            "intervention_name": "Serine/Threonine Kinase Inhibitor",
                            "inclusion_indicator": "TREE",
                            "intervention_type": "Drug",
                            "intervention_description": "",
                            "intervention_category": "Agent Category",
                            "parents": [
                                "C1404"
                            ],
                            "synonyms": []
                        },
                        {
                            "intervention_code": "C1404",
                            "intervention_name": "Protein Kinase Inhibitor",
                            "inclusion_indicator": "TREE",
                            "intervention_type": "Drug",
                            "intervention_description": "",
                            "intervention_category": "Agent Category",
                            "parents": [
                                "C471"
                            ],
                            "synonyms": []
                        },
                        {
                            "intervention_code": "C163758",
                            "intervention_name": "Targeted Therapy Agent",
                            "inclusion_indicator": "TREE",
                            "intervention_type": "Drug",
                            "intervention_description": "",
                            "intervention_category": "Agent Category",
                            "parents": [
                                "C274"
                            ],
                            "synonyms": [
                                "Anti-tumor Targeted Therapy Agent",
                                "Molecularly Targeted Therapy Agent",
                                "Targeted Agent",
                                "Targeted Therapeutic Agent"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "nci_id": "NCI-2019-05356",
            "nct_id": "NCT03988647",
            "protocol_id": "SKIN0047",
            "ccr_id": null,
            "ctep_id": null,
            "dcp_id": null,
            "other_ids": [
                {
                    "name": "Study Protocol Other Identifier",
                    "value": "IRB-50888"
                }
            ],
            "associated_studies": null,
            "outcome_measures": [
                {
                    "name": "Overall survival (OS)",
                    "description": "Overall survival (OS) was assessed as the duration of time from study entry to time of death or the date of last contact.",
                    "timeframe": "5 years",
                    "type_code": "SECONDARY"
                },
                {
                    "name": "Tumor response rate",
                    "description": "Tumor response rates (compete response [CR], partial response [PR], stable disease [SD], immune-related [ir]CR, irPR, irSD) at both irradiated and unirradiated sites will be measured by Response Evaluation Criteria in Solid Tumors (RECIST) version (v)1.1/ immune-related response evaluation criteria in solid tumors (irRECIST) criterion. Complete response (CR) = disappearance of all target lesions. Partial response (PR) = >= 30% decrease in the sum of the longest diameter of target lesions. Stable disease (SD) = small changes that do not meet any of the above criteria. Immune related complete response (irCR) = disappearance of all target lesions. Lymph nodes < 10 mm in short axis. Immune related partial response (irPR) = >= 30% decrease in the sum of the longest diameter of target lesions. Immune related stable disease (irSD) = Failure to meet criteria for irCR or irPR in the absence of immune related partial disease (irPD).",
                    "timeframe": "5 years",
                    "type_code": "PRIMARY"
                },
                {
                    "name": "Duration of response (DOR)",
                    "description": "The duration of overall response is measured from the time measurement criteria are met for CR or PR (whichever is first recorded) until the first date that recurrent or progressive disease is objectively documented (taking as reference for progressive disease the smallest measurements recorded since the treatment started).",
                    "timeframe": "5 years",
                    "type_code": "SECONDARY"
                }
            ],
            "amendment_date": null,
            "current_trial_status": "Active",
            "current_trial_status_date": "2019-07-24",
            "start_date": "2019-07-24",
            "start_date_type_code": "ACTUAL",
            "completion_date": "2026-06-01",
            "completion_date_type_code": "ANTICIPATED",
            "record_verification_date": "2020-04-27",
            "brief_title": "Pembrolizumab and Radiation Therapy for the Treatment of Metastatic Merkel Cell Carcinoma",
            "official_title": "A Phase II Study of Palliative Radiation Therapy and Anti-PD-1 / PD-L1 Checkpoint Blockade in Patients with Metastatic Merkel Cell Carcinoma",
            "acronym": null,
            "keywords": null,
            "brief_summary": "This phase II trial studies the side effects and how well pembrolizumab and radiation therapy work in treating patients with Merkel cell carcinoma that has spread to other places in the body (metastatic). Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Giving pembrolizumab and radiation therapy may increase the benefit of pembrolizumab.",
            "detail_description": "PRIMARY OBJECTIVES:\r\nI. To assess the safety of combining anti-PD-1/PD-L1 blockade with palliative radiation therapy in patients with stage IV Merkel cell carcinoma.\r\nII. To assess the efficacy of combining anti-PD-1/PD-L1 blockade with palliative radiation therapy in patients with stage IV Merkel cell carcinoma.\r\n\r\nSECONDARY OBJECTIVE:\r\nI. Assessment of overall survival and disease control rate/duration of response (complete response [CR], partial response [PR], stable disease [SD], immune-relate [ir]CR, irPR, irSD).\r\n\r\nEXPLORATORY OBJECTIVES:\r\nI. Mutational burden/microsatellite instability (MSI) analysis.\r\nII. Measurement of polyomavirus in the blood.\r\nIII. Immune response assays at baseline, 2 weeks (+/- 1 weeks) and 8 weeks (+/- 1 weeks) after radiation therapy.\r\nIV. Possible tumor biopsy studies.\r\n\r\nOUTLINE:\r\nPatients receive standard of care pembrolizumab intravenously (IV) over 30-60 minutes on day 1. Cycles repeat ever 3 weeks in the absence of disease progression or unacceptable toxicity. Patients also undergo radiation therapy 2-4 weeks after the fourth dose of pembrolizumab (between cycles 1 and 2).\r\n\r\nAfter completion of study treatment, patients are followed up at 2-4 weeks, every 3 months for 2 years, then even 6 months for 3 years.",
            "classification_code": null,
            "interventional_model": "Single Group",
            "study_source": "Institutional",
            "accepts_healthy_volunteers_indicator": "NO",
            "study_protocol_type": "Interventional",
            "study_subtype_code": null,
            "study_population_description": null,
            "study_model_code": null,
            "study_model_other_text": null,
            "sampling_method_code": null,
            "why_study_stopped": null,
            "bio_specimen": {
                "f1": "bio_specimen_description",
                "f2": null,
                "f3": "bio_specimen_retention_code",
                "f4": null
            },
            "primary_purpose": {
                "primary_purpose_code": "TREATMENT",
                "primary_purpose_other_text": null,
                "primary_purpose_additional_qualifier_code": null
            },
            "phase": {
                "phase": "II",
                "phase_other_text": null,
                "phase_additional_qualifier_code": "NO"
            },
            "masking": {
                "masking": null,
                "masking_allocation_code": "NA",
                "masking_role_investigator": null,
                "masking_role_outcome_assessor": null,
                "masking_role_subject": null,
                "masking_role_caregiver": null
            },
            "principal_investigator": "Susan J. Knox",
            "central_contact": {
                "central_contact_email": null,
                "central_contact_name": null,
                "central_contact_phone": null,
                "central_contact_type": null
            },
            "lead_org": "Stanford Cancer Institute Palo Alto",
            "collaborators": [
                {
                    "name": "National Cancer Institute",
                    "functional_role": "FUNDING_SOURCE"
                }
            ],
            "sites": [
                {
                    "contact_email": "sknox@stanford.edu",
                    "contact_name": "Susan J. Knox",
                    "contact_phone": "650-725-2720",
                    "recruitment_status": "ACTIVE",
                    "recruitment_status_date": "2019-07-24",
                    "local_site_identifier": "",
                    "org_address_line_1": "875 Blake Wilbur Drive",
                    "org_address_line_2": null,
                    "org_city": "Palo Alto",
                    "org_country": "United States",
                    "org_email": "ccto-office@stanford.edu",
                    "org_family": "Stanford Cancer Institute",
                    "org_fax": null,
                    "org_name": "Stanford Cancer Institute Palo Alto",
                    "org_to_family_relationship": "ORGANIZATIONAL",
                    "org_phone": "650-498-7061",
                    "org_postal_code": "94304",
                    "org_state_or_province": "CA",
                    "org_status": "ACTIVE",
                    "org_status_date": "2017-08-31",
                    "org_tty": null,
                    "org_va": false,
                    "org_coordinates": {
                        "lat": 37.4059,
                        "lon": -122.1462
                    }
                }
            ],
            "anatomic_sites": [
                "Other Skin"
            ],
            "diseases": [
                {
                    "inclusion_indicator": "TRIAL",
                    "lead_disease_indicator": "NO",
                    "nci_thesaurus_concept_id": "C3813",
                    "preferred_name": "Metastatic Malignant Neoplasm in the Brain",
                    "display_name": "Metastatic Malignant Neoplasm to the Brain",
                    "paths": [
                        {
                            "direction": 1,
                            "concepts": [
                                {
                                    "idx": 0,
                                    "label": "Central Nervous System Neoplasm",
                                    "code": "C9293"
                                },
                                {
                                    "idx": 1,
                                    "label": "Nervous System Neoplasm",
                                    "code": "C3268"
                                }
                            ]
                        }
                    ],
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Brain Metastases",
                        "Brain Metastasis",
                        "Metast. to brain parenchyma, NOS",
                        "Metastases to brain parenchyma, NOS",
                        "Metastatic Malignant Neoplasm in the Brain",
                        "Metastatic Neoplasm to the Brain",
                        "Metastatic Tumor to the Brain",
                        "brain metastasis"
                    ],
                    "parents": [
                        "C3568",
                        "C4015"
                    ]
                },
                {
                    "inclusion_indicator": "TRIAL",
                    "lead_disease_indicator": "NO",
                    "nci_thesaurus_concept_id": "C3814",
                    "preferred_name": "Metastatic Malignant Neoplasm in the Leptomeninges",
                    "display_name": "Metastatic Malignant Neoplasm to the Leptomeninges",
                    "paths": [
                        {
                            "direction": 1,
                            "concepts": [
                                {
                                    "idx": 0,
                                    "label": "Central Nervous System Neoplasm",
                                    "code": "C9293"
                                },
                                {
                                    "idx": 1,
                                    "label": "Nervous System Neoplasm",
                                    "code": "C3268"
                                }
                            ]
                        }
                    ],
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Leptomeningeal Metastases",
                        "Leptomeningeal Metastasis",
                        "Leptomeningeal metastases, NOS",
                        "Metastasis to the Leptomeninges",
                        "Metastatic Malignant Neoplasm in the Leptomeninges",
                        "Metastatic Neoplasm to the Leptomeninges",
                        "Metastatic Tumor to the Leptomeninges",
                        "carcinomatous meningitis",
                        "leptomeningeal carcinoma",
                        "leptomeningeal metastasis",
                        "meningeal metastasis",
                        "neoplastic meningitis"
                    ],
                    "parents": [
                        "C8506",
                        "C4015"
                    ]
                },
                {
                    "inclusion_indicator": "TRIAL",
                    "lead_disease_indicator": "NO",
                    "nci_thesaurus_concept_id": "C136889",
                    "preferred_name": "Pathologic Stage IV Merkel Cell Carcinoma AJCC v8",
                    "display_name": "Pathologic Stage IV Merkel Cell Carcinoma AJCC v8",
                    "paths": [
                        {
                            "direction": 1,
                            "concepts": [
                                {
                                    "idx": 0,
                                    "label": "Skin Carcinoma",
                                    "code": "C4914"
                                }
                            ]
                        }
                    ],
                    "type": [
                        "stage",
                        "grade"
                    ],
                    "synonyms": [
                        "Pathologic Stage IV Neuroendocrine Carcinoma of the Skin AJCC v8"
                    ],
                    "parents": [
                        "C136880"
                    ]
                },
                {
                    "inclusion_indicator": "TRIAL",
                    "lead_disease_indicator": "NO",
                    "nci_thesaurus_concept_id": "C136878",
                    "preferred_name": "Clinical Stage IV Merkel Cell Carcinoma AJCC v8",
                    "display_name": "Clinical Stage IV Merkel Cell Carcinoma AJCC v8",
                    "paths": [
                        {
                            "direction": 1,
                            "concepts": [
                                {
                                    "idx": 0,
                                    "label": "Skin Carcinoma",
                                    "code": "C4914"
                                }
                            ]
                        }
                    ],
                    "type": [
                        "stage",
                        "grade"
                    ],
                    "synonyms": [
                        "Clinical Stage IV Neuroendocrine Carcinoma of the Skin AJCC v8"
                    ],
                    "parents": [
                        "C136871"
                    ]
                },
                {
                    "inclusion_indicator": "TRIAL",
                    "lead_disease_indicator": "YES",
                    "nci_thesaurus_concept_id": "C162572",
                    "preferred_name": "Metastatic Merkel Cell Carcinoma",
                    "display_name": "Metastatic Merkel Cell Carcinoma",
                    "paths": [
                        {
                            "direction": 1,
                            "concepts": [
                                {
                                    "idx": 0,
                                    "label": "Skin Carcinoma",
                                    "code": "C4914"
                                }
                            ]
                        }
                    ],
                    "type": [
                        "grade",
                        "subtype"
                    ],
                    "synonyms": [],
                    "parents": [
                        "C9231",
                        "C170811",
                        "C155869"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C3263",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C3262"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Neoplasm by Site",
                    "preferred_name": "Neoplasm by Site",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": []
                },
                {
                    "nci_thesaurus_concept_id": "C4628",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C4627",
                        "C3229"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Malignant Neoplasm of the Meninges",
                    "preferred_name": "Malignant Neoplasm of the Meninges",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Cancer of Meninges",
                        "Cancer of the Meninges",
                        "Malignant Meningeal Neoplasms",
                        "Malignant Meningeal Tumor",
                        "Malignant Meninges Neoplasm",
                        "Malignant Meninges Tumor",
                        "Malignant Neoplasm of Meninges",
                        "Malignant Neoplasms of Meninges",
                        "Malignant Tumor of Meninges",
                        "Malignant Tumor of the Meninges",
                        "Meningeal Cancer",
                        "Meningeal Tumors, Malignant"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C3773",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C2916",
                        "C3575",
                        "C3809"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Neuroendocrine Cancer",
                    "preferred_name": "Neuroendocrine Carcinoma",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "NEC",
                        "Neuroendocrine Carcinoma",
                        "Neuroendocrine cancer, NOS",
                        "Neuroendocrine carcinoma, NOS"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C7201",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C7062"
                    ],
                    "lead_disease_indicator": "YES",
                    "display_name": "Infrequent Neoplasm",
                    "preferred_name": "Infrequent Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Infrequent Tumor"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C7057",
                    "inclusion_indicator": "TREE",
                    "parents": [],
                    "lead_disease_indicator": "NO",
                    "display_name": "Disease, Disorder or Finding",
                    "preferred_name": "Disease, Disorder or Finding",
                    "type": [],
                    "synonyms": []
                },
                {
                    "nci_thesaurus_concept_id": "C156485",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C36263",
                        "C3809"
                    ],
                    "lead_disease_indicator": "YES",
                    "display_name": "Metastatic Neuroendocrine Neoplasm",
                    "preferred_name": "Metastatic Neuroendocrine Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": []
                },
                {
                    "nci_thesaurus_concept_id": "C27551",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C2991"
                    ],
                    "lead_disease_indicator": "YES",
                    "display_name": "Disorder by Site",
                    "preferred_name": "Disorder by Site",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Disease by Site"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C2934",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C26835"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Central Nervous System Disorder",
                    "preferred_name": "Central Nervous System Disorder",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Central Nervous System Disease",
                        "Disorder of Central Nervous System"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C3773",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C2916",
                        "C3575",
                        "C3809"
                    ],
                    "lead_disease_indicator": "YES",
                    "display_name": "Neuroendocrine Cancer",
                    "preferred_name": "Neuroendocrine Carcinoma",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "NEC",
                        "Neuroendocrine Carcinoma",
                        "Neuroendocrine cancer, NOS",
                        "Neuroendocrine carcinoma, NOS"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C136880",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C136870"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Merkel Cell Carcinoma by AJCC v8 Pathologic Stage",
                    "preferred_name": "Merkel Cell Carcinoma by AJCC v8 Pathologic Stage",
                    "type": [
                        "stage",
                        "grade"
                    ],
                    "synonyms": [
                        "Neuroendocrine Carcinoma of the Skin by AJCC v8 Pathologic Stage"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C4627",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C9293",
                        "C4788"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Malignant Central Nervous System Neoplasm",
                    "preferred_name": "Malignant Central Nervous System Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "CNS Cancer",
                        "CNS Malignant Neoplasms",
                        "CNS Neoplasms, Malignant",
                        "Cancer of CNS",
                        "Cancer of Central Nervous System",
                        "Cancer of the CNS",
                        "Cancer of the Central Nervous System",
                        "Central Nervous System Cancer",
                        "Central Nervous System Neoplasms, Malignant",
                        "Malignant CNS Neoplasm",
                        "Malignant CNS Neoplasms",
                        "Malignant CNS Tumor",
                        "Malignant Central Nervous System Tumor",
                        "Malignant Neoplasm of CNS",
                        "Malignant Neoplasm of Central Nervous System",
                        "Malignant Neoplasm of the CNS",
                        "Malignant Neoplasm of the Central Nervous System",
                        "Malignant Tumor of CNS",
                        "Malignant Tumor of Central Nervous System",
                        "Malignant Tumor of the CNS",
                        "Malignant Tumor of the Central Nervous System"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C3568",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C2907",
                        "C5114"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Malignant Brain Tumor",
                    "preferred_name": "Malignant Brain Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Brain Cancer",
                        "Brain Neoplasms, Malignant",
                        "Cancer of Brain",
                        "Cancer of the Brain",
                        "Malignant Brain Neoplasm",
                        "Malignant Neoplasm of Brain",
                        "Malignant Neoplasm of the Brain",
                        "Malignant Tumor of Brain",
                        "Malignant Tumor of the Brain"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C3009",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C27551"
                    ],
                    "lead_disease_indicator": "YES",
                    "display_name": "Endocrine System Disorder",
                    "preferred_name": "Endocrine System Disorder",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Disorder of Endocrine System",
                        "Endocrine Disease",
                        "Endocrine Disorder",
                        "Endocrinopathy",
                        "Thyroid or other glandular disorders"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C3010",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C3009",
                        "C3709",
                        "C3263"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Endocrine Neoplasm",
                    "preferred_name": "Endocrine Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Endocrine System Neoplasm",
                        "Endocrine System Tumor",
                        "Endocrine Tumor"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C3262",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C2991"
                    ],
                    "lead_disease_indicator": "YES",
                    "display_name": "Other Neoplasm",
                    "preferred_name": "Neoplasm",
                    "type": [
                        "maintype"
                    ],
                    "synonyms": [
                        "Neoplasia",
                        "Neoplasm",
                        "Neoplasm, NOS",
                        "Neoplasms, NOS",
                        "Neoplastic Disease",
                        "Neoplastic Growth",
                        "Tumor, NOS",
                        "neoplasia",
                        "neoplasm",
                        "tumor"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C3371",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C27551"
                    ],
                    "lead_disease_indicator": "YES",
                    "display_name": "Skin Disorder",
                    "preferred_name": "Skin Disorder",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Cutaneous Disorder",
                        "Disorder of Skin",
                        "Skin Diseases and Manifestations",
                        "Skin Disorders"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C3261",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C7062"
                    ],
                    "lead_disease_indicator": "YES",
                    "display_name": "Metastatic Neoplasm",
                    "preferred_name": "Metastatic Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Metastasis",
                        "Metastatic",
                        "Metastatic Disease",
                        "Metastatic Tumor",
                        "Neoplasm, metastatic",
                        "Tumor, metastatic",
                        "metastasis"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C7062",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C3262"
                    ],
                    "lead_disease_indicator": "YES",
                    "display_name": "Neoplasm by Special Category",
                    "preferred_name": "Neoplasm by Special Category",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": []
                },
                {
                    "nci_thesaurus_concept_id": "C9231",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C7201",
                        "C4574",
                        "C173385",
                        "C4914"
                    ],
                    "lead_disease_indicator": "YES",
                    "display_name": "Merkel Cell Cancer",
                    "preferred_name": "Merkel Cell Carcinoma",
                    "type": [
                        "grade",
                        "subtype"
                    ],
                    "synonyms": [
                        "Cutaneous Apudoma",
                        "Cutaneous Neuroendocrine Carcinoma",
                        "MCC",
                        "Merkel Cell Carcinoma",
                        "Merkel cell cancer",
                        "Merkel cell carcinoma",
                        "Merkel cell tumor",
                        "Neuroendocrine Carcinoma of Skin",
                        "Neuroendocrine Carcinoma of the Skin",
                        "Neuroendocrine Skin Carcinoma",
                        "Trabecular Skin Carcinoma",
                        "neuroendocrine carcinoma of the skin",
                        "trabecular cancer"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C2920",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C9305",
                        "C3372"
                    ],
                    "lead_disease_indicator": "YES",
                    "display_name": "Malignant Skin Neoplasm",
                    "preferred_name": "Malignant Skin Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Malignant Neoplasm of Skin",
                        "Malignant Neoplasm of the Skin",
                        "Malignant Skin Tumor",
                        "Malignant Tumor of Skin",
                        "Malignant Tumor of the Skin",
                        "Melanoma and Non-Melanoma Skin Cancer",
                        "Skin Cancer",
                        "Skin Cancer, Including Melanoma",
                        "Skin Neoplasm, Malignant",
                        "Skin cancer, NOS",
                        "skin cancer"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C3709",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C4741"
                    ],
                    "lead_disease_indicator": "YES",
                    "display_name": "Epithelial Neoplasm",
                    "preferred_name": "Epithelial Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Epithelial Neoplasms, NOS",
                        "Epithelioma",
                        "Epithelioma, malignant"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C3009",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C27551"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Endocrine System Disorder",
                    "preferred_name": "Endocrine System Disorder",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Disorder of Endocrine System",
                        "Endocrine Disease",
                        "Endocrine Disorder",
                        "Endocrinopathy",
                        "Thyroid or other glandular disorders"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C2916",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C3709",
                        "C9305"
                    ],
                    "lead_disease_indicator": "YES",
                    "display_name": "Other Carcinoma",
                    "preferred_name": "Carcinoma",
                    "type": [
                        "maintype"
                    ],
                    "synonyms": [
                        "CARCINOMA, MALIGNANT",
                        "Carcinoma",
                        "Carcinoma, NOS",
                        "Epithelial Carcinoma",
                        "Epithelial tumor, malignant",
                        "Epithelioma Malignant",
                        "Malignant Epithelial Neoplasm",
                        "Malignant Epithelial Tumor",
                        "Malignant Epithelioma",
                        "carcinoma",
                        "epithelial carcinoma"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C36263",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C3261",
                        "C4968"
                    ],
                    "lead_disease_indicator": "YES",
                    "display_name": "Metastatic Malignant Neoplasm",
                    "preferred_name": "Metastatic Malignant Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Metastatic Cancer"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C4788",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C9305",
                        "C3268"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Malignant Nervous System Neoplasm",
                    "preferred_name": "Malignant Nervous System Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Malignant Neoplasm of Nervous System",
                        "Malignant Neoplasm of the Nervous System",
                        "Malignant Nervous System Tumor",
                        "Malignant Tumor of Nervous System",
                        "Malignant Tumor of the Nervous System",
                        "Nervous System Neoplasms, Malignant"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C3575",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C3010",
                        "C9305"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Malignant Endocrine Neoplasm",
                    "preferred_name": "Malignant Endocrine Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Endocrine Neoplasm, Malignant",
                        "Endocrine cancer, NOS",
                        "Malignant Endocrine Gland Neoplasm",
                        "Malignant Endocrine Gland Tumor",
                        "Malignant Endocrine Tumor",
                        "Malignant Neoplasm of Endocrine Gland",
                        "Malignant Neoplasm of the Endocrine Gland",
                        "Malignant Tumor of Endocrine Gland",
                        "Malignant Tumor of the Endocrine Gland",
                        "endocrine cancer"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C7201",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C7062"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Infrequent Neoplasm",
                    "preferred_name": "Infrequent Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Infrequent Tumor"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C26835",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C27551"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Nervous System Disorder",
                    "preferred_name": "Nervous System Disorder",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Disorder of Nervous System",
                        "Neurologic Disorder",
                        "Neurological Disorder",
                        "Unspecified Nervous System Problem"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C2907",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C96413",
                        "C4953"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Brain Tumor",
                    "preferred_name": "Brain Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Brain Neoplasm",
                        "Brain Neoplasms",
                        "Neoplasm of Brain",
                        "Neoplasm of the Brain",
                        "Tumor of Brain",
                        "Tumor of the Brain",
                        "brain tumor"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C4574",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C4475",
                        "C2920"
                    ],
                    "lead_disease_indicator": "YES",
                    "display_name": "Malignant Dermal Neoplasm",
                    "preferred_name": "Malignant Dermal Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Malignant Dermis Neoplasm",
                        "Malignant Dermis Tumor",
                        "Malignant Neoplasm of Dermis",
                        "Malignant Neoplasm of the Dermis",
                        "Malignant Tumor of Dermis",
                        "Malignant Tumor of the Dermis"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C3809",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C3010"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Neuroendocrine Tumor",
                    "preferred_name": "Neuroendocrine Neoplasm",
                    "type": [
                        "maintype"
                    ],
                    "synonyms": [
                        "NEN",
                        "Neuroendocrine Neoplasm",
                        "neuroendocrine tumor"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C3482",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C36263",
                        "C36310"
                    ],
                    "lead_disease_indicator": "YES",
                    "display_name": "Metastatic Carcinoma",
                    "preferred_name": "Metastatic Carcinoma",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Carcinoma, metastatic, NOS"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C3010",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C3009",
                        "C3709",
                        "C3263"
                    ],
                    "lead_disease_indicator": "YES",
                    "display_name": "Endocrine Neoplasm",
                    "preferred_name": "Endocrine Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Endocrine System Neoplasm",
                        "Endocrine System Tumor",
                        "Endocrine Tumor"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C3268",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C3263",
                        "C26835"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Nervous System Tumor",
                    "preferred_name": "Nervous System Neoplasm",
                    "type": [
                        "maintype"
                    ],
                    "synonyms": [
                        "Neoplasm of Nervous System",
                        "Neoplasm of the Nervous System",
                        "Nervous System Neoplasm",
                        "Nervous System Neoplasms",
                        "Nervous System Tumour",
                        "Tumor of Nervous System",
                        "Tumor of the Nervous System"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C27551",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C2991"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Disorder by Site",
                    "preferred_name": "Disorder by Site",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Disease by Site"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C3262",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C2991"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Other Neoplasm",
                    "preferred_name": "Neoplasm",
                    "type": [
                        "maintype"
                    ],
                    "synonyms": [
                        "Neoplasia",
                        "Neoplasm",
                        "Neoplasm, NOS",
                        "Neoplasms, NOS",
                        "Neoplastic Disease",
                        "Neoplastic Growth",
                        "Tumor, NOS",
                        "neoplasia",
                        "neoplasm",
                        "tumor"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C4958",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C3229"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Leptomeningeal Neoplasm",
                    "preferred_name": "Leptomeningeal Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "LEPTOMENINGEAL DISEASE",
                        "Leptomeningeal Tumor",
                        "Neoplasm of Leptomeninges",
                        "Neoplasm of the Leptomeninges",
                        "Tumor of Leptomeninges",
                        "Tumor of the Leptomeninges"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C4741",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C3262"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Neoplasm by Morphology",
                    "preferred_name": "Neoplasm by Morphology",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Tumor Morphology",
                        "Tumor_Morphology"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C3372",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C3263",
                        "C3371"
                    ],
                    "lead_disease_indicator": "YES",
                    "display_name": "Skin Tumor",
                    "preferred_name": "Skin Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Neoplasm of Skin",
                        "Neoplasm of the Skin",
                        "Skin Neoplasm",
                        "Skin Neoplasms",
                        "Tumor of Skin",
                        "Tumor of the Skin"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C3371",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C27551"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Skin Disorder",
                    "preferred_name": "Skin Disorder",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Cutaneous Disorder",
                        "Disorder of Skin",
                        "Skin Diseases and Manifestations",
                        "Skin Disorders"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C4574",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C4475",
                        "C2920"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Malignant Dermal Neoplasm",
                    "preferred_name": "Malignant Dermal Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Malignant Dermis Neoplasm",
                        "Malignant Dermis Tumor",
                        "Malignant Neoplasm of Dermis",
                        "Malignant Neoplasm of the Dermis",
                        "Malignant Tumor of Dermis",
                        "Malignant Tumor of the Dermis"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C7062",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C3262"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Neoplasm by Special Category",
                    "preferred_name": "Neoplasm by Special Category",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": []
                },
                {
                    "nci_thesaurus_concept_id": "C7057",
                    "inclusion_indicator": "TREE",
                    "parents": [],
                    "lead_disease_indicator": "YES",
                    "display_name": "Disease, Disorder or Finding",
                    "preferred_name": "Disease, Disorder or Finding",
                    "type": [],
                    "synonyms": []
                },
                {
                    "nci_thesaurus_concept_id": "C4914",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C2916",
                        "C7342",
                        "C2920"
                    ],
                    "lead_disease_indicator": "YES",
                    "display_name": "Non-Melanoma Skin Cancer",
                    "preferred_name": "Skin Carcinoma",
                    "type": [
                        "maintype"
                    ],
                    "synonyms": [
                        "Carcinoma of Skin",
                        "Carcinoma of the Skin",
                        "Non-Melanoma Cancer of Skin",
                        "Non-Melanoma Cancer of the Skin",
                        "Non-melanoma Skin Cancer",
                        "Skin Cancer, Non-Melanoma",
                        "Skin Carcinoma",
                        "nonmelanoma skin cancer"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C3261",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C7062"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Metastatic Neoplasm",
                    "preferred_name": "Metastatic Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Metastasis",
                        "Metastatic",
                        "Metastatic Disease",
                        "Metastatic Tumor",
                        "Neoplasm, metastatic",
                        "Tumor, metastatic",
                        "metastasis"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C2991",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C7057"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Other Disease",
                    "preferred_name": "Disease or Disorder",
                    "type": [
                        "maintype"
                    ],
                    "synonyms": [
                        "Diagnosis",
                        "Disease",
                        "Disease or Disorder",
                        "Disease or Disorder, Non-Neoplastic",
                        "Diseases",
                        "Diseases and Disorders",
                        "Disorder",
                        "Disorders",
                        "condition",
                        "disease",
                        "disease term",
                        "disease type",
                        "disease_term",
                        "disease_type",
                        "disorder"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C9305",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C7062"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Malignant Neoplasm",
                    "preferred_name": "Malignant Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "CA",
                        "Cancer",
                        "Malignancy",
                        "Malignant Growth",
                        "Malignant Neoplastic Disease",
                        "Malignant Tumor",
                        "NEOPLASM, MALIGNANT",
                        "Neoplasm, malignant",
                        "Tumor, malignant, NOS",
                        "Unclassified tumor, malignant",
                        "cancer",
                        "malignancy"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C9305",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C7062"
                    ],
                    "lead_disease_indicator": "YES",
                    "display_name": "Malignant Neoplasm",
                    "preferred_name": "Malignant Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "CA",
                        "Cancer",
                        "Malignancy",
                        "Malignant Growth",
                        "Malignant Neoplastic Disease",
                        "Malignant Tumor",
                        "NEOPLASM, MALIGNANT",
                        "Neoplasm, malignant",
                        "Tumor, malignant, NOS",
                        "Unclassified tumor, malignant",
                        "cancer",
                        "malignancy"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C2916",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C3709",
                        "C9305"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Other Carcinoma",
                    "preferred_name": "Carcinoma",
                    "type": [
                        "maintype"
                    ],
                    "synonyms": [
                        "CARCINOMA, MALIGNANT",
                        "Carcinoma",
                        "Carcinoma, NOS",
                        "Epithelial Carcinoma",
                        "Epithelial tumor, malignant",
                        "Epithelioma Malignant",
                        "Malignant Epithelial Neoplasm",
                        "Malignant Epithelial Tumor",
                        "Malignant Epithelioma",
                        "carcinoma",
                        "epithelial carcinoma"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C9231",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C7201",
                        "C4574",
                        "C173385",
                        "C4914"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Merkel Cell Cancer",
                    "preferred_name": "Merkel Cell Carcinoma",
                    "type": [
                        "grade",
                        "subtype"
                    ],
                    "synonyms": [
                        "Cutaneous Apudoma",
                        "Cutaneous Neuroendocrine Carcinoma",
                        "MCC",
                        "Merkel Cell Carcinoma",
                        "Merkel cell cancer",
                        "Merkel cell carcinoma",
                        "Merkel cell tumor",
                        "Neuroendocrine Carcinoma of Skin",
                        "Neuroendocrine Carcinoma of the Skin",
                        "Neuroendocrine Skin Carcinoma",
                        "Trabecular Skin Carcinoma",
                        "neuroendocrine carcinoma of the skin",
                        "trabecular cancer"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C173385",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C3773"
                    ],
                    "lead_disease_indicator": "YES",
                    "display_name": "Neuroendocrine Carcinoma, Excluding Head and Neck",
                    "preferred_name": "Neuroendocrine Carcinoma, Excluding Head and Neck",
                    "type": [
                        "grade",
                        "subtype"
                    ],
                    "synonyms": []
                },
                {
                    "nci_thesaurus_concept_id": "C136870",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C9231"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Merkel Cell Carcinoma by AJCC v8 Stage",
                    "preferred_name": "Merkel Cell Carcinoma by AJCC v8 Stage",
                    "type": [
                        "stage",
                        "grade"
                    ],
                    "synonyms": [
                        "Neuroendocrine Carcinoma of the Skin by AJCC v8 Stage"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C3575",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C3010",
                        "C9305"
                    ],
                    "lead_disease_indicator": "YES",
                    "display_name": "Malignant Endocrine Neoplasm",
                    "preferred_name": "Malignant Endocrine Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Endocrine Neoplasm, Malignant",
                        "Endocrine cancer, NOS",
                        "Malignant Endocrine Gland Neoplasm",
                        "Malignant Endocrine Gland Tumor",
                        "Malignant Endocrine Tumor",
                        "Malignant Neoplasm of Endocrine Gland",
                        "Malignant Neoplasm of the Endocrine Gland",
                        "Malignant Tumor of Endocrine Gland",
                        "Malignant Tumor of the Endocrine Gland",
                        "endocrine cancer"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C4914",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C2916",
                        "C7342",
                        "C2920"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Non-Melanoma Skin Cancer",
                    "preferred_name": "Skin Carcinoma",
                    "type": [
                        "maintype"
                    ],
                    "synonyms": [
                        "Carcinoma of Skin",
                        "Carcinoma of the Skin",
                        "Non-Melanoma Cancer of Skin",
                        "Non-Melanoma Cancer of the Skin",
                        "Non-melanoma Skin Cancer",
                        "Skin Cancer, Non-Melanoma",
                        "Skin Carcinoma",
                        "nonmelanoma skin cancer"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C4475",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C3372"
                    ],
                    "lead_disease_indicator": "YES",
                    "display_name": "Dermal Neoplasm",
                    "preferred_name": "Dermal Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Dermal Tumor",
                        "Neoplasm of Dermis",
                        "Neoplasm of the Dermis",
                        "Tumor of Dermis",
                        "Tumor of the Dermis"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C36255",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C7062"
                    ],
                    "lead_disease_indicator": "YES",
                    "display_name": "Secondary Neoplasm",
                    "preferred_name": "Secondary Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Neoplasm, secondary",
                        "Secondary Tumor",
                        "Tumor, secondary",
                        "secondary tumor"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C3709",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C4741"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Epithelial Neoplasm",
                    "preferred_name": "Epithelial Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Epithelial Neoplasms, NOS",
                        "Epithelioma",
                        "Epithelioma, malignant"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C36263",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C3261",
                        "C4968"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Metastatic Malignant Neoplasm",
                    "preferred_name": "Metastatic Malignant Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Metastatic Cancer"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C155869",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C3482",
                        "C156485",
                        "C3773"
                    ],
                    "lead_disease_indicator": "YES",
                    "display_name": "Metastatic Neuroendocrine Carcinoma",
                    "preferred_name": "Metastatic Neuroendocrine Carcinoma",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": []
                },
                {
                    "nci_thesaurus_concept_id": "C4968",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C9305",
                        "C36255"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Secondary Malignant Neoplasm",
                    "preferred_name": "Secondary Malignant Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Development of SMN",
                        "Development of Secondary Malignancy Neoplasm",
                        "Secondary Cancer",
                        "Secondary Malignancy",
                        "secondary cancer"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C3809",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C3010"
                    ],
                    "lead_disease_indicator": "YES",
                    "display_name": "Neuroendocrine Tumor",
                    "preferred_name": "Neuroendocrine Neoplasm",
                    "type": [
                        "maintype"
                    ],
                    "synonyms": [
                        "NEN",
                        "Neuroendocrine Neoplasm",
                        "neuroendocrine tumor"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C7342",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C3709",
                        "C3372"
                    ],
                    "lead_disease_indicator": "YES",
                    "display_name": "Epithelial Skin Neoplasm",
                    "preferred_name": "Epithelial Skin Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Epithelial Skin Tumor",
                        "Skin Epithelium Neoplasm",
                        "Skin Epithelium Tumor"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C8506",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C4958",
                        "C4628"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Malignant Leptomeningeal Neoplasm",
                    "preferred_name": "Malignant Leptomeningeal Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Malignant Leptomeningeal Tumor",
                        "Malignant Neoplasm of Leptomeninges",
                        "Malignant Neoplasm of the Leptomeninges",
                        "Malignant Tumor of Leptomeninges",
                        "Malignant Tumor of the Leptomeninges",
                        "leptomeningeal cancer"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C7342",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C3709",
                        "C3372"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Epithelial Skin Neoplasm",
                    "preferred_name": "Epithelial Skin Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Epithelial Skin Tumor",
                        "Skin Epithelium Neoplasm",
                        "Skin Epithelium Tumor"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C136871",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C136870"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Merkel Cell Carcinoma by AJCC v8 Clinical Stage",
                    "preferred_name": "Merkel Cell Carcinoma by AJCC v8 Clinical Stage",
                    "type": [
                        "stage",
                        "grade"
                    ],
                    "synonyms": [
                        "Neuroendocrine Carcinoma of the Skin by AJCC v8 Clinical Stage"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C8547",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C4788",
                        "C36263"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Metastatic Malignant Neoplasm in the Nervous System",
                    "preferred_name": "Metastatic Malignant Neoplasm in the Nervous System",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Metastases to Nervous System",
                        "Metastasis to the Nervous System",
                        "Metastatic Malignant Neoplasm to the Nervous System",
                        "Metastatic Neoplasm to the Nervous System",
                        "Metastatic Tumor to the Nervous System",
                        "Secondary Malignant Neoplasm to the Nervous System",
                        "Secondary Malignant Tumor to the Nervous System"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C173385",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C3773"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Neuroendocrine Carcinoma, Excluding Head and Neck",
                    "preferred_name": "Neuroendocrine Carcinoma, Excluding Head and Neck",
                    "type": [
                        "grade",
                        "subtype"
                    ],
                    "synonyms": []
                },
                {
                    "nci_thesaurus_concept_id": "C3263",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C3262"
                    ],
                    "lead_disease_indicator": "YES",
                    "display_name": "Neoplasm by Site",
                    "preferred_name": "Neoplasm by Site",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": []
                },
                {
                    "nci_thesaurus_concept_id": "C96413",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C2934"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Brain Disorder",
                    "preferred_name": "Brain Disorder",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": []
                },
                {
                    "nci_thesaurus_concept_id": "C36310",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C2916",
                        "C4968"
                    ],
                    "lead_disease_indicator": "YES",
                    "display_name": "Secondary Carcinoma",
                    "preferred_name": "Secondary Carcinoma",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Secondary carcinoma"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C3372",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C3263",
                        "C3371"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Skin Tumor",
                    "preferred_name": "Skin Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Neoplasm of Skin",
                        "Neoplasm of the Skin",
                        "Skin Neoplasm",
                        "Skin Neoplasms",
                        "Tumor of Skin",
                        "Tumor of the Skin"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C4015",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C4627",
                        "C8547"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Metastatic Malignant Neoplasm to the Central Nervous System",
                    "preferred_name": "Metastatic Malignant Neoplasm in the Central Nervous System",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "CNS Metastases",
                        "CNS Metastasis",
                        "CNS metastasis",
                        "Central Nervous System Metastases",
                        "Central Nervous System Metastasis",
                        "Metastatic Malignant Neoplasm in the Central Nervous System",
                        "Metastatic Neoplasm to the CNS",
                        "Metastatic Neoplasm to the Central Nervous System",
                        "Metastatic Tumor to the CNS",
                        "Metastatic Tumor to the Central Nervous System",
                        "central nervous system metastasis"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C36255",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C7062"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Secondary Neoplasm",
                    "preferred_name": "Secondary Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Neoplasm, secondary",
                        "Secondary Tumor",
                        "Tumor, secondary",
                        "secondary tumor"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C2991",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C7057"
                    ],
                    "lead_disease_indicator": "YES",
                    "display_name": "Other Disease",
                    "preferred_name": "Disease or Disorder",
                    "type": [
                        "maintype"
                    ],
                    "synonyms": [
                        "Diagnosis",
                        "Disease",
                        "Disease or Disorder",
                        "Disease or Disorder, Non-Neoplastic",
                        "Diseases",
                        "Diseases and Disorders",
                        "Disorder",
                        "Disorders",
                        "condition",
                        "disease",
                        "disease term",
                        "disease type",
                        "disease_term",
                        "disease_type",
                        "disorder"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C5114",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C4953",
                        "C4627"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Malignant Intracranial Neoplasm",
                    "preferred_name": "Malignant Intracranial Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Intracranial Cancer",
                        "Intracranial Neoplasms, Malignant",
                        "Intracranial Tumors, Malignant",
                        "Malignant Intracranial Tumor"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C4475",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C3372"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Dermal Neoplasm",
                    "preferred_name": "Dermal Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Dermal Tumor",
                        "Neoplasm of Dermis",
                        "Neoplasm of the Dermis",
                        "Tumor of Dermis",
                        "Tumor of the Dermis"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C3229",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C9293"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Meningeal Neoplasm",
                    "preferred_name": "Meningeal Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Meningeal Neoplasms",
                        "Meningeal Tumor",
                        "Meninges Neoplasm",
                        "Meninges Tumor",
                        "Neoplasm of Meninges",
                        "Neoplasm of the Meninges",
                        "Tumor of Meninges",
                        "Tumor of the Meninges"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C4968",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C9305",
                        "C36255"
                    ],
                    "lead_disease_indicator": "YES",
                    "display_name": "Secondary Malignant Neoplasm",
                    "preferred_name": "Secondary Malignant Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Development of SMN",
                        "Development of Secondary Malignancy Neoplasm",
                        "Secondary Cancer",
                        "Secondary Malignancy",
                        "secondary cancer"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C4953",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C9293"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Intracranial Neoplasm",
                    "preferred_name": "Intracranial Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Intracranial Central Nervous System Neoplasm",
                        "Intracranial Central Nervous System Tumor",
                        "Intracranial Tumor",
                        "intracranial tumor"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C4741",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C3262"
                    ],
                    "lead_disease_indicator": "YES",
                    "display_name": "Neoplasm by Morphology",
                    "preferred_name": "Neoplasm by Morphology",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Tumor Morphology",
                        "Tumor_Morphology"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C2920",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C9305",
                        "C3372"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Malignant Skin Neoplasm",
                    "preferred_name": "Malignant Skin Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": [
                        "Malignant Neoplasm of Skin",
                        "Malignant Neoplasm of the Skin",
                        "Malignant Skin Tumor",
                        "Malignant Tumor of Skin",
                        "Malignant Tumor of the Skin",
                        "Melanoma and Non-Melanoma Skin Cancer",
                        "Skin Cancer",
                        "Skin Cancer, Including Melanoma",
                        "Skin Neoplasm, Malignant",
                        "Skin cancer, NOS",
                        "skin cancer"
                    ]
                },
                {
                    "nci_thesaurus_concept_id": "C170811",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C2920",
                        "C36263"
                    ],
                    "lead_disease_indicator": "YES",
                    "display_name": "Metastatic Malignant Skin Neoplasm",
                    "preferred_name": "Metastatic Malignant Skin Neoplasm",
                    "type": [
                        "subtype"
                    ],
                    "synonyms": []
                },
                {
                    "nci_thesaurus_concept_id": "C9293",
                    "inclusion_indicator": "TREE",
                    "parents": [
                        "C2934",
                        "C3268"
                    ],
                    "lead_disease_indicator": "NO",
                    "display_name": "Brain/Spinal Cord Tumor",
                    "preferred_name": "Central Nervous System Neoplasm",
                    "type": [
                        "maintype",
                        "subtype"
                    ],
                    "synonyms": [
                        "CNS Neoplasm",
                        "CNS Tumor",
                        "CNS tumor",
                        "Central Nervous System Neoplasm",
                        "Central Nervous System Tumor",
                        "Neoplasm of CNS",
                        "Neoplasm of Central Nervous System",
                        "Neoplasm of the Central Nervous System",
                        "Tumor of CNS",
                        "Tumor of Central Nervous System",
                        "Tumor of the CNS",
                        "Tumor of the Central Nervous System",
                        "central nervous system tumor"
                    ]
                }
            ],
            "biomarkers": null,
            "minimum_target_accrual_number": 30,
            "eligibility": {
                "structured": {
                    "gender": "BOTH",
                    "max_age": "999 Years",
                    "max_age_number": 999,
                    "max_age_unit": "Years",
                    "min_age": "18 Years",
                    "min_age_number": 18,
                    "min_age_unit": "Years",
                    "max_age_in_years": 999,
                    "min_age_in_years": 18
                },
                "unstructured": [
                    {
                        "display_order": 1,
                        "inclusion_indicator": true,
                        "description": "Histologically confirmed metastatic Merkel cell carcinoma"
                    },
                    {
                        "display_order": 2,
                        "inclusion_indicator": true,
                        "description": "Patients are eligible if they have received no more than 3 prior systemic treatments, inclusive of systemic adjuvant therapy. This includes previously untreated patients"
                    },
                    {
                        "display_order": 3,
                        "inclusion_indicator": true,
                        "description": "Subjects with brain metastases and/or carcinomatous meningitis are eligible providing they are neurologically stable (if systemic steroids are required, subjects should be stable on the lowest clinically effective dose, as steroids may interfere with the activity of immunotherapy if administered at the time of the first anti-PD-1/PD-L1 dose.)"
                    },
                    {
                        "display_order": 4,
                        "inclusion_indicator": true,
                        "description": "Availability of tumor tissue (fresh or archival) for central pathology review"
                    },
                    {
                        "display_order": 5,
                        "inclusion_indicator": true,
                        "description": "Must be at least 14 days since treatment with chemotherapy, biochemotherapy, surgery, or immunotherapy, and recovered (baseline or residual grade 1 toxicity) from any clinically significant toxicity experienced during treatment before the first dose of pembrolizumab therapy"
                    },
                    {
                        "display_order": 6,
                        "inclusion_indicator": true,
                        "description": "Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1"
                    },
                    {
                        "display_order": 7,
                        "inclusion_indicator": true,
                        "description": "Life expectancy of >= 16 weeks"
                    },
                    {
                        "display_order": 8,
                        "inclusion_indicator": true,
                        "description": "Subjects must have measurable disease according to Response Evaluation Criteria in Solid Tumors (RECIST) version (v) 1.1, and have baseline (screening/baseline) radiographic images, (e.g. computed tomography [CT], positron emission tomography [PET] CT or magnetic resonance imaging [MRI] brain, chest, abdomen, pelvis, to be determined by the attending physician) within 4 weeks of confirmation of eligibility and within 6 weeks before the initiation of pembrolizumab therapy"
                    },
                    {
                        "display_order": 9,
                        "inclusion_indicator": true,
                        "description": "White blood count (WBC): >= 2000/uL (~ 2 x 10^9/L)"
                    },
                    {
                        "display_order": 10,
                        "inclusion_indicator": true,
                        "description": "Absolute neutrophil count (ANC): >= 1000/uL (~ 1 x 10^9/L)"
                    },
                    {
                        "display_order": 11,
                        "inclusion_indicator": true,
                        "description": "Platelets: >= 50 x 10^3/uL (~ 50 x 10^9/L)"
                    },
                    {
                        "display_order": 12,
                        "inclusion_indicator": true,
                        "description": "Hemoglobin: >= 8 g/dL"
                    },
                    {
                        "display_order": 13,
                        "inclusion_indicator": true,
                        "description": "Calculated creatinine clearance greater than 30 mL/min"
                    },
                    {
                        "display_order": 14,
                        "inclusion_indicator": true,
                        "description": "Aspartate aminotransferase (AST)/alanine aminotransferase (ALT): Less than 2.5 x upper limit of normal (ULN) for subjects without liver metastasis, less than 5 times ULN for liver metastases"
                    },
                    {
                        "display_order": 15,
                        "inclusion_indicator": true,
                        "description": "Bilirubin: less than 3.0 x ULN (except for subjects with Gilberts syndrome, who must have a total bilirubin of less than 3.0 mg/dL)"
                    },
                    {
                        "display_order": 16,
                        "inclusion_indicator": true,
                        "description": "Non-clinically significant laboratory abnormalities such as lipase elevation would not be an exclusion"
                    },
                    {
                        "display_order": 17,
                        "inclusion_indicator": true,
                        "description": "No known active or chronic infection with human immunodeficiency virus (HIV), hepatitis B, or hepatitis C, or active infection requiring systemic antibiotics. Testing for the above is not required unless clinically suspected"
                    },
                    {
                        "display_order": 18,
                        "inclusion_indicator": true,
                        "description": "At least one measurable site of disease (>= 10 mm as per RECIST v1.1 except for lymph nodes that must be 15 mm or greater on the short axis) outside of the planned palliative radiation therapy field"
                    },
                    {
                        "display_order": 19,
                        "inclusion_indicator": true,
                        "description": "Require radiation therapy for palliation of symptoms or to prevent local progression of disease and associated complications and/or symptoms from metastases"
                    },
                    {
                        "display_order": 20,
                        "inclusion_indicator": true,
                        "description": "Women of childbearing potential (WOCBP) must be using an adequate method of contraception to avoid pregnancy throughout the study (and for up to 26 weeks after the last dose of investigational product) in such a manner that the risk of pregnancy is minimized\r\n* WOCBP include any female who has experienced menarche and who has not undergone successful surgical sterilization (hysterectomy, bilateral tubal ligation, or bilateral oophorectomy) or is not postmenopausal. Post-menopausal is defined as:\r\n** Amenorrhea >= 12 consecutive months without another cause, or\r\n** For women with irregular menstrual periods and on hormone replacement therapy (HRT), a documented serum follicle stimulating hormone (FSH) level > 35 mIU/mL\r\n* Women who are using oral contraceptives, other hormonal contraceptives (vaginal products, skin patches, or implanted or injectable products), or mechanical products such as an intrauterine device or barrier methods (diaphragm, condoms, spermicides) to prevent pregnancy, or are practicing abstinence or where their partner is sterile (e.g., vasectomy) should be considered to be of childbearing potential. WOCBP must have a negative serum or urine pregnancy test (minimum sensitivity 25 IU/L or equivalent units of human chorionic gonadotropin [HCG]) within 1 week prior to the start of investigational product"
                    },
                    {
                        "display_order": 21,
                        "inclusion_indicator": true,
                        "description": "Men of fathering potential must be using an adequate method of contraception to avoid conception throughout the study (and for up to 26 weeks after the last dose of investigational product) in such a manner that the risk of pregnancy is minimized"
                    },
                    {
                        "display_order": 22,
                        "inclusion_indicator": false,
                        "description": "WOCBP who are unwilling or unable to use an acceptable method to avoid pregnancy for the entire study and for up to 26 weeks after the last dose of investigational product"
                    },
                    {
                        "display_order": 23,
                        "inclusion_indicator": false,
                        "description": "Women who are pregnant or breastfeeding"
                    },
                    {
                        "display_order": 24,
                        "inclusion_indicator": false,
                        "description": "Women with a positive pregnancy test on enrollment or before investigational product administration"
                    },
                    {
                        "display_order": 25,
                        "inclusion_indicator": false,
                        "description": "Subjects on any other systemic therapy for cancer, including any other experimental treatment within 2 weeks of scheduled first dose of pembrolizumab"
                    },
                    {
                        "display_order": 26,
                        "inclusion_indicator": false,
                        "description": "Prior treatment with an anti-PD-1/PD-L1 antibody if treatment failure was due to adverse events (AEs). If a subject was discontinued from the prior anti-PD-1/PD-L1 treatment due to an AE or serious adverse event (SAE), regardless of the type of event, that discontinuation constitutes an exclusion criterion. If AEs were serious enough to require a subjects withdrawal from prior treatment, the subject should be excluded from this study. The exception to the above are non-clinically significant immune-related laboratory abnormalities  these are not automatic exclusions  e.g. asymptomatic elevated amylase; responsiveness to steroids. In situations above  e.g. non-clinically significant immune-related laboratory abnormalities, each case will be considered individually and a decision made by the study team"
                    },
                    {
                        "display_order": 27,
                        "inclusion_indicator": false,
                        "description": "A history of AEs with prior interleukin (IL)-2 or interferon will not preclude subjects from entering the current study"
                    },
                    {
                        "display_order": 28,
                        "inclusion_indicator": false,
                        "description": "Poorly controlled autoimmune disease is excluded. Well controlled autoimmune disease (e.g. well controlled rheumatoid arthritis [RA]) will be assessed by the study team and a decision made regarding eligibility based on the degree of immunosuppression and severity of symptoms"
                    },
                    {
                        "display_order": 29,
                        "inclusion_indicator": false,
                        "description": "Any subject who has a life-threatening condition that requires high-dose immunosuppressant(s). Steroid doses greater than 20 mg/day will exclude the patient from participation in the trial."
                    },
                    {
                        "display_order": 30,
                        "inclusion_indicator": false,
                        "description": "Presence of known hepatitis B or hepatitis C infection, regardless of control on antiviral therapy"
                    },
                    {
                        "display_order": 31,
                        "inclusion_indicator": false,
                        "description": "Subjects who have another active, concurrent, malignant disease are not eligible, with the exception of subjects with adequately treated basal or squamous cell skin cancer, superficial bladder cancer, carcinoma in situ of the cervix, or other cancers that are in remission/not measurable. Patients will be excluded if they have any known additional malignancy that requires active treatment while on treatment for Merkel cell carcinoma"
                    },
                    {
                        "display_order": 32,
                        "inclusion_indicator": false,
                        "description": "Bilirubin/total bilirubin 3 or more x ULN unless conjugated bilirubin is less than or equal to the ULN"
                    },
                    {
                        "display_order": 33,
                        "inclusion_indicator": false,
                        "description": "Evidence of symptomatic interstitial lung disease or symptomatic active, noninfectious pneumonitis"
                    },
                    {
                        "display_order": 34,
                        "inclusion_indicator": false,
                        "description": "Participants with impaired cardiac function or clinically significant cardiac disease such as unstable angina/uncompensated heart failure, uncontrolled symptomatic arrhythmia"
                    },
                    {
                        "display_order": 35,
                        "inclusion_indicator": false,
                        "description": "Active autoimmune disease requiring systemic T-cell immunosuppression"
                    },
                    {
                        "display_order": 36,
                        "inclusion_indicator": false,
                        "description": "Chronic or current active infectious disease requiring systemic antibiotics, antifungal, or antiviral treatment. This exclusion does not include prophylactic antibiotics or topical antibiotics"
                    },
                    {
                        "display_order": 37,
                        "inclusion_indicator": false,
                        "description": "Known hypersensitivity to another monoclonal antibody, which cannot be controlled with standard measures (e.g. antihistamines and corticosteroids)"
                    },
                    {
                        "display_order": 38,
                        "inclusion_indicator": false,
                        "description": "Any condition that would, in the investigators judgment, interfere with full participation in the study"
                    },
                    {
                        "display_order": 39,
                        "inclusion_indicator": false,
                        "description": "Prior immune related AEs not meeting the conditions above"
                    },
                    {
                        "display_order": 40,
                        "inclusion_indicator": false,
                        "description": "Prisoners or subjects who are involuntarily incarcerated"
                    },
                    {
                        "display_order": 41,
                        "inclusion_indicator": false,
                        "description": "Subjects with acute or poorly controlled psychiatric illness or subjects who are compulsorily detained for physical (e.g., infectious disease) illness, with the exception of patients that are well supported and able to participate (e.g. paraplegia from a motor vehicle accident)"
                    },
                    {
                        "display_order": 42,
                        "inclusion_indicator": false,
                        "description": "Any underlying medical or psychiatric condition that, in the opinion of the investigator, could make the administration of anti-PD-1/PD-L1 hazardous or could obscure the interpretation of adverse events"
                    },
                    {
                        "display_order": 43,
                        "inclusion_indicator": false,
                        "description": "Any live vaccine therapy for up to 4 weeks before or after any dose of immunotherapy on this trial"
                    },
                    {
                        "display_order": 44,
                        "inclusion_indicator": false,
                        "description": "Any investigational agents within 2 weeks of scheduled first dose of pembrolizumab"
                    }
                ]
            },
            "number_of_arms": 1,
            "arms": [
                {
                    "arm_name": "Treatment (pembrolizumab, radiation therapy)",
                    "arm_type": "EXPERIMENTAL",
                    "arm_description": "Patients receive standard of care pembrolizumab IV over 30-60 minutes on day 1. Cycles repeat ever 3 weeks in the absence of disease progression or unacceptable toxicity. Patients also undergo radiation therapy 2-4 weeks after the fourth dose of pembrolizumab (between cycles 1 and 2).",
                    "interventions": [
                        {
                            "intervention_name": "Pembrolizumab",
                            "intervention_type": "Biological / Vaccine",
                            "intervention_code": "C106432",
                            "intervention_description": "A humanized monoclonal IgG4 antibody directed against human cell surface receptor PD-1 (programmed death-1 or programmed cell death-1) with potential immunopotentiating activity. Upon administration, pembrolizumab binds to PD-1, an inhibitory signaling receptor expressed on the surface of activated T cells, and blocks the binding to and activation of PD-1 by its ligands, which results in the activation of T-cell-mediated immune responses against tumor cells. The ligands for PD-1 include PD-L1, which is expressed on antigen presenting cells (APCs) and overexpressed on certain cancer cells, and PD-L2, which is primarily expressed on APCs. Activated PD-1 negatively regulates T-cell activation through the suppression of the PI3K/Akt pathway. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                            "parents": [
                                "C128037"
                            ],
                            "inclusion_indicator": "TRIAL",
                            "synonyms": [
                                "Keytruda"
                            ],
                            "intervention_category": "Agent"
                        },
                        {
                            "intervention_name": "Radiation Therapy",
                            "intervention_type": "Radiation",
                            "intervention_code": "C15313",
                            "intervention_description": null,
                            "parents": [
                                "C49236"
                            ],
                            "inclusion_indicator": "TRIAL",
                            "synonyms": [
                                "Cancer Radiotherapy",
                                "Irradiate",
                                "Irradiated",
                                "Irradiation",
                                "RT",
                                "Radiation",
                                "Radiotherapeutics",
                                "Radiotherapy",
                                "Therapy, Radiation"
                            ],
                            "intervention_category": "Other"
                        },
                        {
                            "intervention_code": "C128037",
                            "intervention_name": "Anti-PD1 Monoclonal Antibody",
                            "inclusion_indicator": "TREE",
                            "intervention_type": "Biological / Vaccine",
                            "intervention_description": "",
                            "intervention_category": "Agent Category",
                            "parents": [
                                "C20401",
                                "C124946"
                            ],
                            "synonyms": [
                                "Anti-PD-1 Monoclonal Antibody"
                            ]
                        },
                        {
                            "intervention_code": "C20401",
                            "intervention_name": "Monoclonal Antibody Therapy",
                            "inclusion_indicator": "TREE",
                            "intervention_type": "Biological / Vaccine",
                            "intervention_description": "",
                            "intervention_category": "Agent Category",
                            "parents": [
                                "C307",
                                "C308"
                            ],
                            "synonyms": [
                                "Monoclonal Antibodies",
                                "Monoclonal Antibody"
                            ]
                        },
                        {
                            "intervention_code": "C307",
                            "intervention_name": "Biological Agent",
                            "inclusion_indicator": "TREE",
                            "intervention_type": "Biological / Vaccine",
                            "intervention_description": "",
                            "intervention_category": "Agent Category",
                            "parents": [
                                "C1909"
                            ],
                            "synonyms": [
                                "Biological Products",
                                "Biologicals",
                                "Biologics",
                                "Biopharmaceuticals",
                                "Immunologic, Immunochemical",
                                "Immunologics"
                            ]
                        },
                        {
                            "intervention_code": "C1909",
                            "intervention_name": "Pharmacologic Substance",
                            "inclusion_indicator": "TREE",
                            "intervention_type": "Biological / Vaccine",
                            "intervention_description": "",
                            "intervention_category": "Agent Category",
                            "parents": [
                                "C1908"
                            ],
                            "synonyms": [
                                "Agent",
                                "Drug",
                                "Drug Substance",
                                "Pharmaceutical Agent",
                                "Pharmaceuticals",
                                "Pharmacologic Agent",
                                "Pharmacological Substance"
                            ]
                        },
                        {
                            "intervention_code": "C1908",
                            "intervention_name": "Drug, Food, Chemical or Biomedical Material",
                            "inclusion_indicator": "TREE",
                            "intervention_type": "Biological / Vaccine",
                            "intervention_description": "",
                            "intervention_category": "Agent Category",
                            "parents": [],
                            "synonyms": []
                        },
                        {
                            "intervention_code": "C308",
                            "intervention_name": "Immunotherapy",
                            "inclusion_indicator": "TREE",
                            "intervention_type": "Biological / Vaccine",
                            "intervention_description": "",
                            "intervention_category": "Agent Category",
                            "parents": [
                                "C1909"
                            ],
                            "synonyms": [
                                "BRM",
                                "Biological Response Modifier",
                                "Biomodulators",
                                "Immune Mediators",
                                "Immune Modulators",
                                "Immune Regulators",
                                "Immunomodulating Agent",
                                "Immunomodulators",
                                "Immunomodulatory Agent",
                                "Immunopotentiators",
                                "Immunotherapy Agent",
                                "Immunotherapeutic Agent"
                            ]
                        },
                        {
                            "intervention_code": "C124946",
                            "intervention_name": "PD1 Inhibitor",
                            "inclusion_indicator": "TREE",
                            "intervention_type": "Biological / Vaccine",
                            "intervention_description": "",
                            "intervention_category": "Agent Category",
                            "parents": [
                                "C143250",
                                "C163758"
                            ],
                            "synonyms": [
                                "PD-1 Inhibitor",
                                "PD-1-targeting Agent",
                                "Programmed Cell Death Protein 1 Inhibitor",
                                "Protein PD-1 Inhibitor"
                            ]
                        },
                        {
                            "intervention_code": "C143250",
                            "intervention_name": "Immune Checkpoint Inhibitor",
                            "inclusion_indicator": "TREE",
                            "intervention_type": "Biological / Vaccine",
                            "intervention_description": "",
                            "intervention_category": "Agent Category",
                            "parents": [
                                "C141144"
                            ],
                            "synonyms": []
                        },
                        {
                            "intervention_code": "C141144",
                            "intervention_name": "Immune Checkpoint Modulator",
                            "inclusion_indicator": "TREE",
                            "intervention_type": "Biological / Vaccine",
                            "intervention_description": "",
                            "intervention_category": "Agent Category",
                            "parents": [
                                "C308"
                            ],
                            "synonyms": []
                        },
                        {
                            "intervention_code": "C163758",
                            "intervention_name": "Targeted Therapy Agent",
                            "inclusion_indicator": "TREE",
                            "intervention_type": "Biological / Vaccine",
                            "intervention_description": "",
                            "intervention_category": "Agent Category",
                            "parents": [
                                "C274"
                            ],
                            "synonyms": [
                                "Anti-tumor Targeted Therapy Agent",
                                "Molecularly Targeted Therapy Agent",
                                "Targeted Agent",
                                "Targeted Therapeutic Agent"
                            ]
                        },
                        {
                            "intervention_code": "C274",
                            "intervention_name": "Antineoplastic Agent",
                            "inclusion_indicator": "TREE",
                            "intervention_type": "Biological / Vaccine",
                            "intervention_description": "",
                            "intervention_category": "Agent Category",
                            "parents": [
                                "C1909"
                            ],
                            "synonyms": [
                                "Anti-Cancer Agents",
                                "Anti-Tumor Agents",
                                "Anti-Tumor Drugs",
                                "Antineoplastic Drugs",
                                "Antineoplastics",
                                "Antiproliferative Agents",
                                "Antiproliferative Drugs",
                                "Cancer Drug",
                                "Chemotherapeutic Agents, Neoplastic Disease",
                                "Tumor-Specific Treatment Agents"
                            ]
                        },
                        {
                            "intervention_code": "C49236",
                            "intervention_name": "Therapeutic Procedure",
                            "inclusion_indicator": "TREE",
                            "intervention_type": "Radiation",
                            "intervention_description": "",
                            "intervention_category": "NONE",
                            "parents": [
                                "C25218"
                            ],
                            "synonyms": [
                                "TX",
                                "Therapeutic Interventions",
                                "Therapeutic Method",
                                "Therapeutic Technique",
                                "Therapy"
                            ]
                        },
                        {
                            "intervention_code": "C25218",
                            "intervention_name": "Intervention or Procedure",
                            "inclusion_indicator": "TREE",
                            "intervention_type": "Radiation",
                            "intervention_description": "",
                            "intervention_category": "NONE",
                            "parents": [
                                "C16203"
                            ],
                            "synonyms": [
                                "Intervention",
                                "Intervention Strategies",
                                "Procedure"
                            ]
                        },
                        {
                            "intervention_code": "C16203",
                            "intervention_name": "Clinical or Research Activity",
                            "inclusion_indicator": "TREE",
                            "intervention_type": "Radiation",
                            "intervention_description": "",
                            "intervention_category": "NONE",
                            "parents": [
                                "C43431"
                            ],
                            "synonyms": []
                        },
                        {
                            "intervention_code": "C43431",
                            "intervention_name": "Activity",
                            "inclusion_indicator": "TREE",
                            "intervention_type": "Radiation",
                            "intervention_description": "",
                            "intervention_category": "NONE",
                            "parents": [],
                            "synonyms": []
                        }
                    ]
                }
            ]
        }
       
        
    ]
}